Use of wind-up fetal Doppler versus Pinard for fetal heart rate intermittent monitoring in labour: a randomised clinical trial. by Byaruhanga, R et al.
Byaruhanga, R; Bassani, DG; Jagau, A; Muwanguzi, P; Montgomery,
AL; Lawn, JE (2015) Use of wind-up fetal Doppler versus Pinard
for fetal heart rate intermittent monitoring in labour: a randomised
clinical trial. BMJ Open, 5 (1). e006867. ISSN 2044-6055 DOI:
10.1136/bmjopen-2014-006867
Downloaded from: http://researchonline.lshtm.ac.uk/2090895/
DOI: 10.1136/bmjopen-2014-006867
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
For peer review only
 
 
 
Use of wind-up fetal Doppler versus Pinard for fetal heart 
rate intermittent monitoring in labour: a randomised clinical 
trial 
 
 
Journal: BMJ Open 
Manuscript ID: bmjopen-2014-006867 
Article Type: Research 
Date Submitted by the Author: 14-Oct-2014 
Complete List of Authors: Byaruhanga, Romano; St. Raphael of St.Francis Hospital Nsambya, 
Obstetrics and Gynaecology 
Bassani, D; University of Toronto, Centre for Global Child Health 
Jagau, Anneke; Powerfree Education and Technology,  
Muwanguzi, Paul; Uganda Martyrs Hospital Rubaga, Obstetrics and 
Gynecology 
Montgomery, Ann; Hospital for Sick Children, Centre for Global Child 
Health 
Lawn, Joy; London School of Hygiene & Tropical Medicine,  
<b>Primary Subject 
Heading</b>: 
Obstetrics and gynaecology 
Secondary Subject Heading: Epidemiology 
Keywords: Fetal medicine < OBSTETRICS, NEONATOLOGY, PRIMARY CARE 
  
 
 
For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml
BMJ Open
For peer review only
 1 
Use of wind-up fetal Doppler versus Pinard for fetal heart rate intermittent monitoring in labour: a 
randomised clinical trial 
 
Byaruhanga R* 
Institution: St. Raphael of St.Francis Hospital Nsambya 
Department: Obstetrics and Gynaecology  
Address: P.O.Box 7146, Kampala,Uganda 
byaruhangarn@yahoo.com 
 
Bassani DG* 
Institution: Hospital for Sick Children 
Department: Centre for Global Child Health 
Address: 525 Bay St Suite 702 Toronto Canada M5G 2L3 
Email: diego.bassani@sickkids.ca 
 
Jagau A 
Institution: Powerfree Education and Technology 
Address: 14 Benjamin Road Cape Town 
Email: annekejagau@gmail.com 
 
Muwanguzi P 
Institution: Uganda Martyrs Hospital Rubaga 
Department: Obstetrics and Gynecology 
Address: Rubaga Hill Kampala Uganda 
Email: paul.muwanguzi@gmail.com 
 
Montgomery AL  
Institution: Hospital for Sick Children 
Department: Centre for Global Child Health 
Address: 525 Bay St Suite 702 Toronto Canada M5G 2L3 
Email: ann.montgomery@sickkids.ca 
 
Lawn JE 
Institution: London School of Hygiene & Tropical Medicine 
Department: Direct of MARCH (Maternal Reproductive & Child Health) 
Address: Keppel St, London United Kingdom WC1E 7HT 
Email: joy.lawn@lshtm.ac.uk 
 
*Joint first authors 
 
MeSH Keywords - Clinical trial; Randomized controlled trial; Labor, obstetrics; Fetal hypoxia; 
Fetal anoxia; Neonatal mortality; Stillbirth 
 
Word count: 
Page 1 of 17
For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml
BMJ Open
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For peer review only
 2 
TITLE: Use of wind-up fetal Doppler versus Pinard for fetal heart rate intermittent monitoring in 
labour: a randomized clinical trial 
 
AUTHORS: Byaruhanga R*, Bassani DG*, Jagau A, Muwanguzi P, Montgomery AL, Lawn JE 
*Joint first authors 
 
ABSTRACT 
 
Objectives: In resource-poor settings, the standard of care to inform labour management is the 
partograph plus Pinard stethoscope for intermittent fetal heart rate (FHR) monitoring. We 
compared FHR monitoring in labour using a novel, robust wind-up handheld Doppler with the 
Pinard as a primary screening tool for abnormal FHR on perinatal outcomes.  
 
Design: Prospective equally randomised clinical trial. 
 
Setting: The labour and delivery unit of a teaching hospital in Kampala, Uganda. 
 
Participants: Of the 2042 eligible antenatal women, 1971 women in active term labour, following  
uncomplicated pregnancies were randomised to either the standard of care, or not. 
 
Intervention: Intermittent FHR monitoring using Doppler. 
 
Primary outcome measures: Incidence of FHR abnormality detection, intrapartum stillbirth and 
neonatal mortality prior to discharge. 
 
Results: Age, parity, gestational age, mode of delivery, and newborn weight were similar between 
study groups. In the Doppler group, there was a significantly higher rate of FHR abnormalities 
detected (Incidence Rate Ratio (IRR)=1.61, 95%CI 1.13 to 2.30). However, in this group there 
were also higher though not statistically significant rate of intrapartum stillbirths (IRR=3.94, 0.44 
to 35.24) and neonatal deaths (IRR=1.38, 0.44 to 4.34).   
 
Conclusion: Routine monitoring with a handheld Doppler increased the identification of FHR 
abnormalities in labour; however, our trial did not find evidence that this lead to a decrease the 
incidence of intrapartum stillbirth or neonatal death.  
 
Trial registration: ClinicalTrails.gov (1000031587) 
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TEXT BOXES 
 
1. Strengths and limitations of this study 
 
• This is the first study to use current monitoring guidelines to compare evaluated Doppler 
versus Pinard in improving stillbirth and neonatal outcomes.  
• A major strength of this study includes the prospective and randomisation design. 
• We were unable to perform secondary screening of suspected fetal hypoxia through the use 
of cardiotography; nor confirm for the presence of fetal hypoxia acidemia via fetal blood 
scalp sampling, and cord blood gases; therefore we were unable to assess if the 
identification (or lack of identification) of abnormal FHR was correlated with the presence 
of fetal hypoxia acidemia.  
• We were unable to exclude some cases where the underlying cause of death was other than 
fetal hypoxia (e.g. congenital anomalies, early onset sepsis) due to diagnostic limitations in 
differentially diagnosing these cases.  
 
 
2. Training 
 
Helping Babies Survive Labour is the training programme that was used to train the midwives in 
Nsambya hospital.  It was developed by Powerfree Education and Technology in Cape Town in 
collaboration with Save the Children and health professionals from Nsambya Hospital Kampala 
(Figure 3).  
Many training methods and guidelines are written in high income countries and are simply 
transferred for use in low income countries, although the healthcare workers in these countries 
may face very different challenges. Input was solicited from both the healthcare workers and 
academics in the target country in the preparation of these training materials.  
The material first provides a section of evidence-based theory that will help health workers to 
understand why monitoring of the fetal heart is important. This is followed by practical lessons on 
how to monitor fetal well-being, how to interpret observations and recordings and most 
importantly, gives guidelines on what to do when something is wr ng. The training is developed 
in such a way that it can be used along side the Helping Babies Breath training material, which 
focuses on neonatal resuscitation.  
 
Before this trial started, midwives and doctors were trained. Fifty-two people attended the 
training and 42 completed both the pre- and post-test. The average score for the pre-test was 
49.7% (median 50%). The average score for the post-test was 67.9% (median 69%). It does 
reveal the low baseline knowledge on appropriate intrapartum care and illustrates the need for 
continuous quality improvement.  
For link to the manual and its references 
http://www.healthynewbornnetwork.org/sites/default/files/resources/HBSL%20training%20bookle
t.pdf  
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INTRODUCTION 
 
Approximately 44% of all child deaths under the age of 5 years occur in neonates (<28 days of 
age).[1] The third largest cause of neonatal mortality is intrapartum-related hypoxia (formerly 
called `birth asphyxia’) resulting in an estimated 660 000 neonatal deaths per year globally[1] and 
an additional 414,000 children who survive with disability.[2] There are also an estimated 1.02 
million intrapartum stillbirths almost all in low and middle income countries.[3] This burden is 
highest in areas of the world where the probability of quality of care at birth  is the lowest.[4] In 
order to reduce the incidence of intrapartum-related stillbirths and neonatal deaths, it is necessary 
to assess fetal well-being in labour with routine monitoring of the fetal heart rate (FHR), linked to 
rapid and effective  management with resuscitative measures or prompt delivery, and provision of 
neonatal resuscitation if needed.  
 
Characteristic FHR changes often precede brain injury via a process of progressive fetal hypoxic 
acidemia.[5] Intermittent auscultation as a primary screening tool to monitor fetal well-being is the 
recommended standard of care for women experiencing uncomplicated deliveries.[6-9] One 
method of intermittent auscultation uses the Pinard Fetal Stethoscope (Pinard), a trumpet shaped 
horn, to monitor the FHR and is widely adopted as the standard of care in resource-poor settings 
since it is low cost and does not require a power source or repairs. The difficulties posed in using a 
Pinard are generally not conducive to a busy labour ward. It requires additional time to precisely 
locate the fetal heart as the heart is only audible within a very narrow area of the woman's 
abdomen, it requires that the surrounding area be quiet in order to hear the fetal heart, the reading 
can be unreliable in obese women, and it requires the midwife to place her ear in close proximity 
to the woman's pubic area. In addition the midwife usually counts the FHR for short time, such as 
15 seconds, and multiplies to reach beats/minute, further decreasing accuracy and introducing 
arithmetic errors. The handheld Doppler ultrasound fetal heart rate monitor (Doppler) detects FHR 
and provides a steady state number per minute, as well as audible auscultation of the FHR. It 
requires a reliable power source and may need repairs, and is more costly than a Pinard. However, 
it permits the midwife to quickly locate the FHR, allows others including the mother to hear the 
FHR, permits the woman to remain in any comfortable position while being assessed, permits the 
midwife to both assess the FHR and communicate to the woman the status of her baby, and has 
been shown to be preferred by women over the use of the Pinard.[8,10] A rugged, wind-up, 
handheld Doppler fetal heart rate monitor (Doppler) developed by Power-free Education 
Technology (Pet.og.za) showed in initial field tests to be accurate and acceptable to both mother 
and midwives in low-resource settings.[11,12] It uses a hand crank to generate 2:30 minutes of use 
for every 30 seconds of cranking. 
 
While there have been several studies showing reduced intervention and no improved outcomes in 
the use of the intermittent (Pinard or Doppler) versus continuous cardiotocography (CTG) 
monitoring as the primary screening tool in uncomplicated deliveries,[6,13] there is little research 
on outcomes in intermittent monitoring comparing Doppler versus Pinard. A single study by 
Mohamed et al using a monitoring protocol of 10 minutes every half-hour found higher detection 
of FHR abnormalities and better perinatal outcomes in the intermittent auscultation Doppler group 
compared with the Pinard group.[14] 
 
We aimed to use a randomised trial design to compare the primary screening methods of FHR 
monitoring (Doppler as intervention versus Pinard as standard of care) on incidence of detection of 
FHR abnormalities, and on the incidence of intrapartum stillbirth and neonatal mortality in the first 
24 hours after delivery.  
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METHODS 
 
Study design and participants 
We undertook this randomised controlled trial at San Raphael of St. Francis Nsambya Hospital, a 
peri-urban private not-for-profit hospital in Kampala, Uganda. It is a teaching hospital that 
manages 7 500 deliveries annually. CTG and fetal blood gas sampling to support labour 
management, and epidural pain medication are not available. Oxytocin augmentation and 
Caesarean delivery rates are 40% and 20% respectively. The standard of care for intrapartum FHR 
monitoring is by intermittent auscultation using the Pinard.  
 
Women were requested to participate during an antenatal care appointment.  This consent was 
reconfirmed in labour provided that they presented in labour with a singleton pregnancy, in a 
cephalic position, at term or post-term (>37 weeks gestation). Women were excluded if they were 
already in second stage of labour upon admission or had a high risk pregnancy, such as 
preeclampsia or antepartum hemorrhage; if there was a diagnosis of intrauterine fetal death upon 
admission; or if the woman was admitted for an elective Caesarean delivery. Participants were 
presented with information about the study, and agreeing participants provided written consent. 
This study was approved by Sickkids Research Ethics Board, Nsambya Internal Review Board, as 
well as the Uganda National Council for Science and Technology. Registration of our protocol 
with ClinicalTrials.gov occurred before participant enrolment started, but due to an administrative 
error with our institution's Clinical Research Services Unit, the protocol was only released to the 
public after the completion of the study. Documentation from the Chair of our independent 
Research Ethics Board was provided to BMJ Open attesting to the version of the protocol 
provided to them prior to the start of enrolment. 
 
Randomisation 
Women were equally randomised to one of the two study methods using sequentially numbered, 
opaque sealed envelopes. Study participants and care providers where not blinded to the 
intervention. Data were collected from the patient's partograph and from the hospital’s routine 
neonatal mortality audit data, when applicable.  
 
Procedures 
The standard of care for intrapartum monitoring relied on partograph and FHR monitoring with 
the Pinard. Our pre-study training address deficiencies in monitoring standards (acceptable range 
for FHR, recognition of accelerations, decelerations, and change in baseline). We developed a 
training module entitled “Helping Babies Survive Labour” modeling on the “Helping Babies 
Breathe” visual materials and learning approach. The technical basis was from World Health 
Organisation (WHO) and Canadian Obstetric Society protocols.[5] All midwives and doctors 
were then given this in-service training for half a day. FHR monitoring was undertaken every 30 
minutes in first stage of labour; every 15 minutes in second stage before pushing; and every 5 
minutes in second stage when pushing and for 1 minute immediately after a contraction. The 
baseline FHR was recorded as a single number rather than a range, in the unit of beats per minute 
(bpm). The FHR rhythm (regular or irregular) and absence or presence of accelerations or 
decelerations were also documented. The maternal pulse was simultaneously palpated to 
differentiate it with the FHR.  
 
When FHR abnormalities are identified the standard of care would be to switch from intermittent 
auscultation to CTG. Since CTG is not available in Nsambya Hospital, any noted FHR 
abnormalities were reported by the research midwife to the doctor on duty for assessment. 
Management following this assessment was either closer intermittent monitoring, or intra-uterine 
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resuscitation with re-assessment of the FHR. Intra-uterine resuscitation consisted of maternal 
position change, administration of oxygen by mask to mother, initiation of intravenous infusion, 
discontinuation of oxytocin augmentation, and consider prompt delivery (assisted vaginal if 
imminent, otherwise by Caesarean). 
 
Outcomes 
The primary outcome measures of interest were detection of FHR abnormality in labour (defined 
below), intrapartum stillbirth, and neonatal deaths in the first 24 hours of life. Fetal heart rate 
abnormality is defined as tachycardia, bradycardia, or atypical variable, late or prolonged 
decelerations. Tachycardia and bradycardia are defined as baselines of >160 bpm and <110 bpm, 
respectively. Some features of atypical variable decelerations are abrupt fetal heart rate 
decelerations, lasting >2 minutes, slow return to baseline, or in the presence of tachycardia. Late 
decelerations are a repetitive, gradual decrease in the FHR and return to baseline, commencing 
after the onset of the contraction, and return to baseline after the end of the contraction. Prolonged 
decelerations are a decrease from baseline of >15 bpm lasting from 2-10 minutes. Secondary 
outcomes were Apgar score less than 7 at 5 minutes, admission to special care unit for intrapartum-
related complications (intrapartum hypoxia, neonatal encephalopathy, or meconium aspiration 
syndrome), diagnosis of neonatal encephalopathy (NE), and delivery by Caesarean.  A validated 
and simplified scoring method was used for grading mild, moderate and severe NE.[15,16] 
 
Statistical analysis 
Estimating that the use of the Doppler would reduce intrapartum stillbirth by 30% compared to the 
Pinard (based on the results of Mohamed et al 1994),[14] with 80% power to detect at least a 30% 
reduction in stillbirths with 95% confidence, we would need to enroll 840 participates in each of 
the two comparison groups. We added 20% to the sample size for each study arm to account for 
loss to follow-up and statistical adjustments and stratification, resulting in 1008 participants 
required for each comparison group. 
 
Data were double entered from the partograph and, where applicable, the hospital's routine 
neonatal mortality audit document. An interim analysis was conducted by the data safety and 
monitoring board at the mid-point of the data collection period. Descriptive statistics were used to 
describe the characteristics of the participants and their outcomes under each study arm.  
 
We used population-averaged generalized Poisson regression modeling to compare methods of 
FHR monitoring with Doppler versus Pinard on incidence rate ratio (IRR) of detection of FHR 
abnormalities, intrapartum stillbirth, and neonatal mortality. We conducted a sub-group analysis 
and qualitative reporting on the intrapartum stillbirths and a pre-discharge neonatal deaths within 
24 hours and those fetuses with detected abnormal FHR. 
 
All analyses were conducted using Stata/SE (StataCorp. 2011. Stata Statistical Software: Release 
12. College Station, TX: StataCorp LP). 
 
Role of funding source 
The sponsor had no role in designing the study, analysing data, collecting data, interpreting the 
results, writing the report, or the decision to submit the paper for publication. The corresponding 
author had complete access to all the data. 
 
RESULTS 
 
From July 2012 to December 2013, we screened 2042 women antenatally. Fifty-three women were 
ineligible (50 planned to deliver elsewhere, 3 planned Caesarean delivery); 2 women declined to 
Page 6 of 17
For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml
BMJ Open
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For peer review only
 7 
participate; 1987 were enrolled (Figure 1). After assignment to a monitoring method, 8 of the 987 
in the Pinard arm were excluded from analysis (1 lost to follow up, 1 delivered before the 
partograph was started, 2 undiagnosed breech births, 4 undiagnosed multiple births); and 8 of the 
1000 in the Doppler arm were excluded (3 delivered before the partograph was started, 3 
undiagnosed breech births, 2 undiagnosed multiple births). The final study group was n=979 in the 
Pinard arm and n=992 in the Doppler arm. 
 
Of the 1971 women analyzed, the median maternal age was 26 years (IQR 24-30) (Table 1). There 
were a slightly higher though not statistically significant number of post-term women (≥42 weeks 
of gestational age) in the Doppler versus the Pinard arm (54/992 (5.4%) versus 41/979 (4.2%), 
p=0.193).  A similar proportion of women in the Doppler versus the Pinard arm were primiparous 
(395/992 (39.8%) versus 413/979 (42.2%)), with similar median gestational age (39 weeks, IQR 
38-40), and similar median newborn weight (3300g, IQR 3000-3500g).  
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Table 1: Demographic, clinical and perinatal characteristics 
 
  Pinard (n=979) Doppler (n=992) p-value 
Maternal age (years) Median (IQR) 26 (23-30) 27 (24-30) 0.95 
Marital status Married 816 (83.4) 818 (82.5) 0.60 
 Single 163 (16.7) 174 (17.5)  
Maternal education None 9 (0.9) 7 (0.7) 0.62 
 Primary 93 (9.5) 94 (9.5)  
 Secondary 385 (39.3) 423 (42.6)  
 Vocational 235 (24.0) 224 (22.6)  
 University 257 (26.3) 243 (24.5)  
 Missing  1 (0.1)  
Maternal occupation Housewife 357 (36.5) 377 (38.0) 0.80 
 Skilled worker 84 (8.6) 75 (7.6)  
 Self-employed 271 (27.7) 260 (26.2)  
 Professional 252 (25.7) 262 (26.4)  
 Other 15 (1.5) 18 (1.8)  
No. of ANC visits Median (IQR) 4 (3-5) 4 (3-5) 0.58 
Complication noted in 
pregnancy Yes 17 (98.3) 24 (2.4) 0.29 
 No 962 (1.7) 968 (97.6)  
Gravity 1 334 (34.1) 332 (33.5) 0.64 
 2 422 (43.1) 416 (41.9)  
 ≥3 223 (22.8) 244 (24.6)  
Parity 0 413 (42.2) 395 (39.8) 0.31 
 1 238 (24.3) 232 (23.4)  
 ≥2 328 (33.5) 365 (36.8)  
Previous perinatal death Yes 24 (2.5) 29 (2.9) 0.52 
 No 955 (97.6) 963 (97.1)  
Malarial IPTp Yes 914 (93.4) 923 (93.0) 0.78 
 No 65 (6.6) 69 (7.0)  
Syphilis Negative 830 (84.8) 869 (87.6) 0.14 
 Positive 11 (1.1) 6 (0.6)  
 Missing 138 (14.1) 117 (11.8)  
HIV Status Negative 887 (90.6) 892 (89.9) 0.55 
 Positive 46 (4.7) 57 (5.6)  
 Missing 46 (4.7) 43 (4.3)  
Gestational age at 
delivery (weeks) Median (IQR) 39 (38-40) 39 (38-40) 0.80 
Postterm gestation (≥42 
weeks) Yes 41 (4.2) 54 (5.4) 0.19 
 No 938 (95.8) 938 (94.6)  
Newborn weight (g) Median (IQR) 3300 (3000-3500) 3300 (3000-3500) 0.70 
Data are n (%) or median (IQR); IPTp - Intermittent preventative treatment in pregnancy; HIV - Human 
immunodeficiency virus 
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Table 2: Secondary outcomes by treatment group 
  Pinard (n=979) Doppler (n=992) p-value 
Management of FHR 
abnormality  IU resuscitation 15 (1.5) 30 (3.0) 0.04 
 Assisted 7 (0.7) 4 (0.4)  
 Cesarean 39 (4.0) 55 (5.5)  
 Not applicable 918 (93.8) 903 (91.1)  
Length of 1st stage  (hh:mm) 6:30 (4:15-8:20) 6:30 (4:12-8:06) 0.64 
Length of 2nd stage  (hh:mm) 0:10 (00:05-00:15) 0:10 (00:5-00:15) 0.37 
Oxytocin augmentation Yes 407 (41.9) 402 (40.5) 0.42 
 No 520 (53.6) 554 (55.8)  
 Missing 52 (5.4) 36 (3.6)  
Amniotic fluid Clear 768 (78.5) 758 (76.4) 0.28 
 Meconium 211 (21.5) 234 (23.6)  
Apgar <7 at 5 min <7 17 (1.7) 23 (2.3) 0.40 
 ≥7 961 (98.2) 969 (97.7)  
     
 Missing 1 (0.1) 0 (0.0)  
Type of delivery Vaginal 813 (83.0) 817 (82.4) 0.69 
 Caesarean 166 (17.0) 175 (17.6)  
Admission to NICU
* 
Yes 36 (3.7) 48 (4.8) 0.20 
 No 943 (96.3) 944 (95.2)  
Data are n (%) or median (IQR); FHR - fetal heart rate; IU - intrauterine resuscitation; NICU - neonatal 
intensive care unit; 
*
for asphyxia, neonatal encephalopathy, or meconium aspiration syndrome 
 
 
Similar proportions of women in the Doppler versus Pinard arm had Caesarean deliveries (175/992 
(17.6%) versus 166/979 (17.0%), p=0.695) (Table 2). Data on duration of ruptured membranes 
were not collected.  
 
There were a significantly higher number of FHR abnormalities detected in the Doppler versus 
Pinard arm (75/992 (7.6%) versus 46/979 (4.7%), p=0.008, IRR=1.61, 95%CI 1.13-2.30) (Table 
3). There were a higher though not statistically significant number of intrapartum stillbirths in the 
Doppler versus Pinard arm (4/988 (0.4%) versus 1/977 (0.1%), p=0.184, IRR=3.94, 95%CI 0.44-
35.24), and higher number of neonatal deaths prior to discharge (7/985 (0.7%) versus 5//973 
(0.5%), p=0.579, IRR=1.38, 95%CI 0.44-4.34).  
 
There were 121 cases of abnormal FHR detected in labour (Figure 2). Of the 17 deaths in total 
(intrapartum stillbirths and neonatal deaths prior to discharge), 5 were associated with the detection 
of abnormal FHR in labour. In a subgroup analysis of those cases where abnormal FHR was 
detected, there were a higher though not statistically significant proportion of deaths in the Doppler 
versus Pinard arm (4/71 (5.3%) vs 1/45 (2.2%), IRR=2.45 95%CI 0.28-21.47). The remaining 12 
deaths who had a normal FHR reported; 3 had missing cause of death, and 1 had a congenital 
anomaly, and cause of death for the remaining 8 was intrauterine hypoxia, respiratory distress, or 
neonatal encephalopathy, suggesting that an abnormal FHR was a missed diagnosis in labour for 
these 8 deaths.  
 
Table 3: Primary outcomes by treatment group 
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Pinard 
(n=979) 
Doppler 
(n=992) p value  IRR
*
 (95% CI) p value 
Abnormality 
detected Yes 46 (4.7) 75 (7.6) 0.008 1.61 (1.13 to 2.30) 0.009 
 No 933 (95.3) 917 (92.4)    
Intrapartum 
stillbirth Yes 1 (0.1) 4 (0.4) 0.184 3.94
**
 (0.44 to 35.24) 0.219 
 No 977 (99.9) 988 (99.6)    
 Missing 1 0    
        
Neonatal death 
prior to discharge Yes 5 (0.5) 7 (0.7) 0.579 1.38
**
 (0.44 to 4.34) 0.552 
 No 973 (99.5) 985 (99.3)    
 Missing 1     
IRR - incidence rate ratio; 
*
not adjusted, significant baseline characteristics (p value <0.2) were tested and 
did not influence measu e of effect in the model 
**
excludes missing from analysis 
 
DISCUSSION 
 
Detection of abnormal FHR in labour is essential for identifying the fetus in need of responsive 
management such as prompt delivery. We report that intermittent auscultation with a Doppler 
identifies 60% more in need of prompt delivery (IRR=1.61); however, we did not find that this 
identification resulted in a significant decrease in mortality, although one would expect that higher 
detection should lead to prompt delivery and improved outcomes.  
 
We propose a number of explanations for this lack of detected impact. We considered that there 
may have been a learning curve for staff using the Doppler as a new technology; however, we 
found no difference in outcomes over time or between groups (data not shown). Secondly, it is 
possible that use of technology such as the Doppler lead to false reassurance that FHR was being 
closely monitored, delayed involvement of senior staff and subsequent delivery, or there may 
simply have been delay between recognition and action that, by chance, had more deleterious 
effects in the intervention group. Thirdly this study sample size and power was based on the 
Mohamed 1994 study, aiming to detect a 30% reduction in intrapartum stillbirth in the Doppler 
compared to the Pinard group and this may be optimistic, necessitating a larger sample size to 
demonstrate any improved outcomes given the improved detection rates in the Doppler group.  
 
Some study limitations include that we were unable to perform secondary screening of suspected 
fetal hypoxia through the use of cardiotography; nor confirm for the presence of fetal hypoxia 
acidemia via fetal blood scalp sampling, and cord blood gases; therefore we were unable to assess 
if the identification (or lack of identification) of abnormal FHR was correlated with the presence of 
fetal hypoxia acidemia. In addition, we were unable to exclude some cases where the underlying 
cause of death was other than fetal hypoxia (e.g. congenital anomalies, early onset sepsis) due to 
diagnostic limitations in differentially diagnosing these cases. Finally, the screening process was 
all linked to the partograph which has well recognized limitations.[17]  
 
In conclusion, routine monitoring with a handheld Doppler increases the proportion of fetuses 
identified in need of prompt delivery via the identification of FHR abnormalities in labour.  
The care providers and the women expressed preferences for the Doppler, however, we did not 
find evidence that this lead to a decrease in the incidence of intrapartum stillbirth or neonatal death. 
This study demonstrates the need for further larger study with linkage to rapid response for 
abnormal FHR, including caesarean section to ensure that increased detection leads to decreased  
Page 10 of 17
For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml
BMJ Open
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For peer review only
 11
death and disability.  
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CONSORT 2010 checklist of information to include when reporting a randomised trial* 
 
Section/Topic 
Item 
No Checklist item 
Reported 
on page No 
Title and abstract 
 1a Identification as a randomised trial in the title 1 
1b Structured summary of trial design, methods, results, and conclusions (for specific guidance see CONSORT for abstracts) 2 
Introduction 
Background and 
objectives 
2a Scientific background and explanation of rationale 4 
2b Specific objectives or hypotheses 4 
Methods 
Trial design 3a Description of trial design (such as parallel, factorial) including allocation ratio 5 
3b Important changes to methods after trial commencement (such as eligibility criteria), with reasons not applicable 
Participants 4a Eligibility criteria for participants 5 
4b Settings and locations where the data were collected 5 
Interventions 5 The interventions for each group with sufficient details to allow replication, including how and when they were 
actually administered 
5 
Outcomes 6a Completely defined pre-specified primary and secondary outcome measures, including how and when they 
were assessed 
6 
6b Any changes to trial outcomes after the trial commenced, with reasons not applicable 
Sample size 7a How sample size was determined 6 
7b When applicable, explanation of any interim analyses and stopping guidelines 6 
Randomisation:    
 Sequence 
generation 
8a Method used to generate the random allocation sequence not reported 
8b Type of randomisation; details of any restriction (such as blocking and block size) 5 
 Allocation 
concealment 
mechanism 
9 Mechanism used to implement the random allocation sequence (such as sequentially numbered containers), 
describing any steps taken to conceal the sequence until interventions were assigned 
5 
 Implementation 10 Who generated the random allocation sequence, who enrolled participants, and who assigned participants to 
interventions 
5 
Blinding 11a If done, who was blinded after assignment to interventions (for example, participants, care providers, those 5 
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assessing outcomes) and how 
11b If relevant, description of the similarity of interventions 5 
Statistical methods 12a Statistical methods used to compare groups for primary and secondary outcomes 6 
12b Methods for additional analyses, such as subgroup analyses and adjusted analyses 6 
Results 
Participant flow (a 
diagram is strongly 
recommended) 
13a For each group, the numbers of participants who were randomly assigned, received intended treatment, and 
were analysed for the primary outcome 
Figure 1, 6-7 
13b For each group, losses and exclusions after randomisation, together with reasons Figure 1, 6-7 
Recruitment 14a Dates defining the periods of recruitment and follow-up 6 
14b Why the trial ended or was stopped 6 
Baseline data 15 A table showing baseline demographic and clinical characteristics for each group 8 
Numbers analysed 16 For each group, number of participants (denominator) included in each analysis and whether the analysis was 
by original assigned groups 
8 
Outcomes and 
estimation 
17a For each primary and secondary outcome, results for each group, and the estimated effect size and its 
precision (such as 95% confidence interval) 
10 
17b For binary outcomes, presentation of both absolute and relative effect sizes is recommended 10 
Ancillary analyses 18 Results of any other analyses performed, including subgroup analyses and adjusted analyses, distinguishing 
pre-specified from exploratory 
9 
Harms 19 All important harms or unintended effects in each group (for specific guidance see CONSORT for harms) Table 2, 9 
Discussion 
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, multiplicity of analyses 10 
Generalisability 21 Generalisability (external validity, applicability) of the trial findings 10 
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and considering other relevant evidence 10 
Other information  
Registration 23 Registration number and name of trial registry 2 
Protocol 24 Where the full trial protocol can be accessed, if available 2 
Funding 25 Sources of funding and other support (such as supply of drugs), role of funders 2 
 
*We strongly recommend reading this statement in conjunction with the CONSORT 2010 Explanation and Elaboration for important clarifications on all the items. If relevant, we also 
recommend reading CONSORT extensions for cluster randomised trials, non-inferiority and equivalence trials, non-pharmacological treatments, herbal interventions, and pragmatic trials. 
Additional extensions are forthcoming: for those and for up to date references relevant to this checklist, see www.consort-statement.org. 
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ABSTRACT 
 
Objectives: In resource-poor settings, the standard of care to inform labour management is the 
partograph plus Pinard stethoscope for intermittent fetal heart rate (FHR) monitoring. We 
compared FHR monitoring in labour using a novel, robust wind-up handheld Doppler with the 
Pinard as a primary screening tool for abnormal FHR on perinatal outcomes.  
 
Design: Prospective equally randomised clinical trial. 
 
Setting: The labour and delivery unit of a teaching hospital in Kampala, Uganda. 
 
Participants: Of the 2042 eligible antenatal women, 1971 women in active term labour, following  
uncomplicated pregnancies were randomised to either the standard of care, or not. 
 
Intervention: Intermittent FHR monitoring using Doppler. 
 
Primary outcome measures: Incidence of FHR abnormality detection, intrapartum stillbirth and 
neonatal mortality prior to discharge. 
 
Results: Age, parity, gestational age, mode of delivery, and newborn weight were similar between 
study groups. In the Doppler group, there was a significantly higher rate of FHR abnormalities 
detected (Incidence Rate Ratio (IRR)=1.61, 95%CI 1.13 to 2.30). However, in this group there 
were also higher though not statistically significant rate of intrapartum stillbirths (IRR=3.94, 0.44 
to 35.24) and neonatal deaths (IRR=1.38, 0.44 to 4.34).   
 
Conclusion: Routine monitoring with a handheld Doppler increased the identification of FHR 
abnormalities in labour; however, our trial did not find evidence that this lead to a decrease the 
incidence of intrapartum stillbirth or neonatal death.  
 
Trial registration: ClinicalTrails.gov (1000031587) 
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TEXT BOXES 
 
1. Strengths and limitations of this study 
 
• This is the first study to use current monitoring guidelines to compare evaluated Doppler 
versus Pinard in improving stillbirth and neonatal outcomes.  
• A major strength of this study includes the prospective and randomisation design. 
• We were unable to perform secondary screening of suspected fetal hypoxia through the use 
of cardiotography; nor confirm for the presence of fetal hypoxia acidemia via fetal blood 
scalp sampling, and cord blood gases; therefore we were unable to assess if the 
identification (or lack of identification) of abnormal FHR was correlated with the presence 
of fetal hypoxia acidemia.  
• We were unable to exclude some cases where the underlying cause of death was other than 
fetal hypoxia (e.g. congenital anomalies, early onset sepsis) due to diagnostic limitations in 
differentially diagnosing these cases.  
 
 
2. Training 
 
Helping Babies Survive Labour is the training programme that was used to train the midwives in 
Nsambya hospital.  It was developed by Powerfree Education and Technology in Cape Town in 
collaboration with Save the Children and health professionals from Nsambya Hospital Kampala 
(Figure 3).  
Many training methods and guidelines are written in high income countries and are simply 
transferred for use in low income countries, although the healthcare workers in these countries 
may face very different challenges. Input was solicited from both the healthcare workers and 
academics in the target country in the preparation of these training materials.  
The material first provides a section of evidence-based theory that will help health workers to 
understand why monitoring of the fetal heart is important. This is followed by practical lessons on 
how to monitor fetal well-being, how to interpret observations and recordings and most 
importantly, gives guidelines on what to do when something is wr ng. The training is developed 
in such a way that it can be used along side the Helping Babies Breath training material, which 
focuses on neonatal resuscitation.  
 
Before this trial started, midwives and doctors were trained. Fifty-two people attended the 
training and 42 completed both the pre- and post-test. The average score for the pre-test was 
49.7% (median 50%). The average score for the post-test was 67.9% (median 69%). It does 
reveal the low baseline knowledge on appropriate intrapartum care and illustrates the need for 
continuous quality improvement.  
For link to the manual and its references 
http://www.healthynewbornnetwork.org/sites/default/files/resources/HBSL%20training%20bookle
t.pdf
Page 3 of 29
For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml
BMJ Open
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For peer review only
 4 
 
 
INTRODUCTION 
 
Approximately 44% of all child deaths under the age of 5 years occur in neonates (<28 days of 
age).[1] The third largest cause of neonatal mortality is intrapartum-related hypoxia (formerly 
called `birth asphyxia’) resulting in an estimated 660 000 neonatal deaths per year globally[1] and 
an additional 414,000 children who survive with disability.[2] There are also an estimated 1.02 
million intrapartum stillbirths almost all in low and middle income countries.[3] This burden is 
highest in areas of the world where the probability of quality of care at birth  is the lowest.[4] In 
order to reduce the incidence of intrapartum-related stillbirths and neonatal deaths, it is necessary 
to assess fetal well-being in labour with routine monitoring of the fetal heart rate (FHR), linked to 
rapid and effective  management with resuscitative measures or prompt delivery, and provision of 
neonatal resuscitation if needed.  
 
Characteristic FHR changes often precede brain injury via a process of progressive fetal hypoxic 
acidemia.[5] Intermittent auscultation as a primary screening tool to monitor fetal well-being is the 
recommended standard of care for women experiencing uncomplicated deliveries.[6-9] One 
method of intermittent auscultation uses the Pinard Fetal Stethoscope (Pinard), a trumpet shaped 
horn, to monitor the FHR and is widely adopted as the standard of care in resource-poor settings 
since it is low cost and does not require a power source or repairs. The difficulties posed in using a 
Pinard are generally not conducive to a busy labour ward. It requires additional time to precisely 
locate the fetal heart as the heart is only audible within a very narrow area of the woman's 
abdomen, it requires that the surrounding area be quiet in order to hear the fetal heart, the reading 
can be unreliable in obese women, and it requires the midwife to place her ear in close proximity 
to the woman's pubic area. In addition the midwife usually counts the FHR for short time, such as 
15 seconds, and multiplies to reach beats/minute, further decreasing accuracy and introducing 
arithmetic errors. The handheld Doppler ultrasound fetal heart rate monitor (Doppler) detects FHR 
and provides a steady state number per minute, as well as audible auscultation of the FHR. It 
requires a reliable power source and may need repairs, and is more costly than a Pinard. However, 
it permits the midwife to quickly locate the FHR, allows others including the mother to hear the 
FHR, permits the woman to remain in any comfortable position while being assessed, permits the 
midwife to both assess the FHR and communicate to the woman the status of her baby, and has 
been shown to be preferred by women over the use of the Pinard.[8,10] A rugged, wind-up, 
handheld Doppler fetal heart rate monitor (Doppler) developed by Power-free Education 
Technology (Pet.og.za) showed in initial field tests to be accurate and acceptable to both mother 
and midwives in low-resource settings.[11,12] It uses a hand crank to generate 2:30 minutes of use 
for every 30 seconds of cranking. 
 
While there have been several studies showing reduced intervention and no improved outcomes in 
the use of the intermittent (Pinard or Doppler) versus continuous cardiotocography (CTG) 
monitoring as the primary screening tool in uncomplicated deliveries,[6,13] there is little research 
on outcomes in intermittent monitoring comparing Doppler versus Pinard. A single study by 
Mohamed et al using a monitoring protocol of 10 minutes every half-hour found higher detection 
of FHR abnormalities and better perinatal outcomes in the intermittent auscultation Doppler group 
compared with the Pinard group.[14] 
 
We aimed to use a randomised trial design to compare the primary screening methods of FHR 
monitoring (Doppler as intervention versus Pinard as standard of care) on incidence of detection of 
FHR abnormalities, and on the incidence of intrapartum stillbirth and neonatal mortality in the first 
24 hours after delivery.  
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METHODS 
 
Study design and participants 
We undertook this randomised controlled trial at San Raphael of St. Francis Nsambya Hospital, a 
peri-urban private not-for-profit hospital in Kampala, Uganda. It is a teaching hospital that 
manages 7 500 deliveries annually. CTG and fetal blood gas sampling to support labour 
management, and epidural pain medication are not available. Oxytocin augmentation and 
Caesarean delivery rates are 40% and 20% respectively. The standard of care for intrapartum FHR 
monitoring is by intermittent auscultation using the Pinard.  
 
Women were requested to participate during an antenatal care appointment.  This consent was 
reconfirmed in labour provided that they presented in labour with a singleton pregnancy, in a 
cephalic position, at term or post-term (>37 weeks gestation). Women were excluded if they were 
already in second stage of labour upon admission or presented with a condition that, according to 
the doctor on duty, contra-indicated labouring (e.g. antepartum hemorrhage); if there was a 
diagnosis of intrauterine fetal death upon admission; or if the woman was admitted for an elective 
Caesarean delivery. Participants were presented with information about the study, and agreeing 
participants provided written consent. This study was approved by Sickkids Research Ethics 
Board, Nsambya Internal Review Board, as well as the Uganda National Council for Science and 
Technology. Registration of our protocol with ClinicalTrials.gov occurred before 
participant enrolment started, but due to an administrative error with our institution's Clinical 
Research Services Unit, the protocol was only released to the public after the completion of the 
study. Documentation from the Chair of our independent Research Ethics Board was provided to 
BMJ Open attesting to the version of the protocol provided to them prior to the start of enrolment. 
 
Randomisation 
Women were equally randomised to one of the two study methods using sequentially numbered, 
opaque sealed envelopes. Study participants and care providers where not blinded to the 
intervention. Data were collected from the patient's partograph and from the hospital’s routine 
neonatal mortality audit data, when applicable.  
 
Procedures 
The standard of care for intrapartum monitoring relied on partograph and FHR monitoring with 
the Pinard. Our pre-study training address deficiencies in monitoring standards (acceptable range 
for FHR, recognition of accelerations, decelerations, and change in baseline). We developed a 
training module entitled “Helping Babies Survive Labour” modeling on the “Helping Babies 
Breathe” visual materials and learning approach. The technical basis was from World Health 
Organisation (WHO) and Canadian Obstetric Society protocols.[5] All midwives and doctors 
were then given this in-service training for half a day. FHR monitoring was undertaken every 30 
minutes in first stage of labour; every 15 minutes in second stage before pushing; and every 5 
minutes in second stage when pushing and for 1 minute immediately after a contraction. The 
baseline FHR was recorded as a single number rather than a range, in the unit of beats per minute 
(bpm). The FHR rhythm (regular or irregular) and absence or presence of accelerations or 
decelerations were also documented. The maternal radial pulse was simultaneously palpated to 
differentiate it with the FHR.  
 
When FHR abnormalities are identified the standard of care would be to switch from intermittent 
auscultation to CTG. Since CTG is not available in Nsambya Hospital, any noted FHR 
abnormalities were reported by the research midwife to the doctor on duty for assessment. 
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Management following this assessment was either closer intermittent monitoring, or intra-uterine 
resuscitation with re-assessment of the FHR. Intra-uterine resuscitation consisted of maternal 
position change, administration of oxygen by mask to mother, initiation of intravenous infusion, 
discontinuation of oxytocin augmentation, and consider prompt delivery (assisted vaginal if 
imminent, otherwise by Caesarean). 
 
Outcomes 
The primary outcome measures of interest were detection of FHR abnormality in labour (defined 
below), intrapartum stillbirth, and neonatal deaths in the first 24 hours of life. Fetal heart rate 
abnormality is defined as tachycardia, bradycardia, or atypical variable, late or prolonged 
decelerations. Tachycardia and bradycardia are defined as baselines of >160 bpm and <110 bpm, 
respectively. Some features of atypical variable decelerations are abrupt fetal heart rate 
decelerations, lasting >2 minutes, slow return to baseline, or in the presence of tachycardia. Late 
decelerations are a repetitive, gradual decrease in the FHR and return to baseline, commencing 
after the onset of the contraction, and return to baseline after the end of the contraction. Prolonged 
decelerations are a decrease from baseline of >15 bpm lasting from 2-10 minutes. Secondary 
outcomes were Apgar score less than 7 at 5 minutes, admission to special care unit for intrapartum-
related complications (intrapartum hypoxia, neonatal encephalopathy, or meconium aspiration 
syndrome), diagnosis of neonatal encephalopathy (NE), and delivery by Caesarean.  A validated 
and simplified scoring method was used for grading mild, moderate and severe NE.[15,16] 
Indications for Caesarean delivery were failure to progress (as indicated by crossing of the action 
line on the partograph), abnormal FHR unresponsive to uterine resuscitation, and identification of 
malpresentation in labour (e.g. conversion from vertex to brow or mentum posterior). 
 
Statistical analysis 
Estimating that the use of the Doppler would reduce intrapartum stillbirth by 30% compared to the 
Pinard (based on the results of Mohamed et al 1994),[14] with 80% power to detect at least a 30% 
reduction in stillbirths with 95% confidence, we would need to enroll 840 participates in each of 
the two comparison groups. We added 20% to the sample size for each study arm to account for 
loss to follow-up and statistical adjustments and stratification, resulting in 1008 participants 
required for each comparison group. 
 
Data were double entered from the partograph and, where applicable, the hospital's routine 
neonatal mortality audit document. An interim analysis was conducted by the data safety and 
monitoring board at the mid-point of the data collection period. Descriptive statistics were used to 
describe the characteristics of the participants and their outcomes under each study arm.  
We used population-averaged generalized Poisson regression modeling with robust variance to 
compare methods of FHR monitoring with Doppler versus Pinard on incidence rate ratio (IRR) of 
detection of FHR abnormalities, intrapartum stillbirth, and neonatal mortalit  (see Barros et al for 
details of this choice over logistic regression [17]). We conducted a sub-group analysis and 
qualitative reporting on the intrapartum stillbirths and pre-discharge neonatal deaths within 24 
hours and those fetuses with detected abnormal FHR. 
 
All analyses were conducted using Stata/SE (StataCorp. 2011. Stata Statistical Software: Release 
12. College Station, TX: StataCorp LP). 
 
Role of funding source 
The sponsor had no role in designing the study, analysing data, collecting data, interpreting the 
results, writing the report, or the decision to submit the paper for publication. The corresponding 
author had complete access to all the data. 
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RESULTS 
 
From July 2012 to December 2013, we screened 2042 women antenatally. Fifty-three women were 
ineligible (50 planned to deliver elsewhere, 3 planned Caesarean delivery); 2 women declined to 
participate; 1987 were enrolled (Figure 1). After assignment to a monitoring method, 8 of the 987 
in the Pinard arm were excluded from analysis (1 lost to follow up, 1 delivered before the 
partograph was started, 2 undiagnosed breech births, 4 undiagnosed multiple births); and 8 of the 
1000 in the Doppler arm were excluded (3 delivered before the partograph was started, 3 
undiagnosed breech births, 2 undiagnosed multiple births). The final study group was n=979 in the 
Pinard arm and n=992 in the Doppler arm. 
 
Of the 1971 women analyzed, the median maternal age was 26 years (IQR 24-30) (Table 1). There 
were a slightly higher though not statistically significant number of post-term women (≥42 weeks 
of gestational age) in the Doppler versus the Pinard arm (54/992 (5.4%) versus 41/979 (4.2%), 
p=0.193).  A similar proportion of women in the Doppler versus the Pinard arm were primiparous 
(395/992 (39.8%) versus 413/979 (42.2%)), with similar median gestational age (39 weeks, IQR 
38-40), and similar median newborn weight (3300g, IQR 3000-3500g).  
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Table 1: Demographic, clinical and perinatal characteristics 
 
  Pinard (n=979) Doppler (n=992) p-value 
Maternal age (years) Median (IQR) 26 (23-30) 27 (24-30) 0.95 
Marital status Married 816 (83.4) 818 (82.5) 0.60 
 Single 163 (16.7) 174 (17.5)  
Maternal education None 9 (0.9) 7 (0.7) 0.62 
 Primary 93 (9.5) 94 (9.5)  
 Secondary 385 (39.3) 423 (42.6)  
 Vocational 235 (24.0) 224 (22.6)  
 University 257 (26.3) 243 (24.5)  
 Missing  1 (0.1)  
Maternal occupation Housewife 357 (36.5) 377 (38.0) 0.80 
 Skilled worker 84 (8.6) 75 (7.6)  
 Self-employed 271 (27.7) 260 (26.2)  
 Professional 252 (25.7) 262 (26.4)  
 Other 15 (1.5) 18 (1.8)  
No. of ANC visits Median (IQR) 4 (3-5) 4 (3-5) 0.58 
Complication noted in 
pregnancy Yes 17 (98.3) 24 (2.4) 0.29 
 No 962 (1.7) 968 (97.6)  
Gravity 1 334 (34.1) 332 (33.5) 0.64 
 2 422 (43.1) 416 (41.9)  
 ≥3 223 (22.8) 244 (24.6)  
Parity 0 413 (42.2) 395 (39.8) 0.31 
 1 238 (24.3) 232 (23.4)  
 ≥2 328 (33.5) 365 (36.8)  
Previous perinatal death Yes 24 (2.5) 29 (2.9) 0.52 
 No 955 (97.6) 963 (97.1)  
Malarial IPTp Yes 914 (93.4) 923 (93.0) 0.78 
 No 65 (6.6) 69 (7.0)  
Syphilis Negative 830 (84.8) 869 (87.6) 0.14 
 Positive 11 (1.1) 6 (0.6)  
 Missing 138 (14.1) 117 (11.8)  
HIV Status Negative 887 (90.6) 892 (89.9) 0.55 
 Positive 46 (4.7) 57 (5.6)  
 Missing 46 (4.7) 43 (4.3)  
Gestational age at 
delivery (weeks) Median (IQR) 39 (38-40) 39 (38-40) 0.80 
Postterm gestation (≥42 
weeks) Yes 41 (4.2) 54 (5.4) 0.19 
 No 938 (95.8) 938 (94.6)  
Newborn weight (g) Median (IQR) 3300 (3000-3500) 3300 (3000-3500) 0.70 
Data are n (%) or median (IQR); IPTp - Intermittent preventative treatment in pregnancy; HIV - Human 
immunodeficiency virus 
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There were no differences between the study arms in Apgar score <7 at 5 minutes (23 (2.3%) in 
the Doppler versus 17(1.7%)  the Painard, p=0.40) or admission to neonatal intensive care unit for 
any reason (48(4.8%) in the Doppler versus 36(3.7%) the Pinard, p=0.20). Similar proportions of 
women in the Doppler versus Pinard arm had Caesarean deliveries (175/992 (17.6%) versus 
166/979 (17.0%), p=0.695).  
 
There were a significantly higher number of FHR abnormalities detected in the Doppler versus 
Pinard arm (75/992 (7.6%) versus 46/979 (4.7%), p=0.008, IRR=1.61, 95%CI 1.13-2.30) (Table 
2). There were a higher though not statistically significant number of intrapartum stillbirths in the 
Doppler versus Pinard arm (4/988 (0.4%) versus 1/977 (0.1%), p=0.184, IRR=3.94, 95%CI 0.44-
35.24), and higher number of neonatal deaths prior to discharge (7/985 (0.7%) versus 5//973 
(0.5%), p=0.579, IRR=1.38, 95%CI 0.44-4.34).  
 
There were 121 cases of abnormal FHR detected in labour (Figure 2). Of the 17 deaths in total 
(intrapartum stillbirths and neonatal deaths prior to discharge), 5 were associated with the detection 
of abnormal FHR in labour. In a subgroup analysis of those cases where abnormal FHR was 
detected, there were a higher though not statistically significant proportion of deaths in the Doppler 
versus Pinard arm (4/71 (5.3%) vs 1/45 (2.2%), IRR=2.45 95%CI 0.28-21.47). The remaining 12 
deaths who had a normal FHR reported; 3 had missing cause of death, and 1 had a congenital 
anomaly, and cause of death for the remaining 8 was intrauterine hypoxia, respiratory distress, or 
neonatal encephalopathy, suggesting that an abnormal FHR was a missed diagnosis in labour for 
these 8 deaths.  
 
Table 2: Primary outcomes by treatment group 
    
Pinard 
(n=979) 
Doppler 
(n=992) p value  IRR
*
 (95% CI) p value 
Abnormality 
detected Yes 46 (4.7) 75 (7.6) 0.008 1.61 (1.13 to 2.30) 0.009 
 No 933 (95.3) 917 (92.4)    
Intrapartum 
stillbirth Yes 1 (0.1) 4 (0.4) 0.184 3.94
**
 (0.44 to 35.24) 0.219 
 No 977 (99.9) 988 (99.6)    
 Missing 1 0    
        
Neonatal death 
prior to discharge Yes 5 (0.5) 7 (0.7) 0.579 1.38
**
 (0.44 to 4.34) 0.552 
 No 973 (99.5) 985 (99.3)    
 Missing 1     
IRR - incidence rate ratio; 
*
not adjusted, significant baseline characteristics (p value <0.2) were tested and 
did not influence measure of effect in the model 
**
excludes missing from analysis 
 
DISCUSSION 
 
Detection of abnormal FHR in labour is essential for identifying the fetus in need of responsive 
management such as prompt delivery. We report that intermittent auscultation with a Doppler 
identifies 60% more in need of prompt delivery (IRR=1.61); however, we did not find that this 
identification resulted in a significant decrease in mortality, although one would expect that higher 
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detection should lead to prompt delivery and improved outcomes.  
 
We propose a number of explanations for this lack of detected impact. We considered that there 
may have been a learning curve for staff using the Doppler as a new technology; however, we 
found no difference in outcomes over time or between groups (data not shown). Secondly, it is 
possible that use of technology such as the Doppler lead to false reassurance that FHR was being 
closely monitored, delayed involvement of senior staff and subsequent delivery, or there may 
simply have been delay between recognition and action that, by chance, had more deleterious 
effects in the intervention group. Thirdly this study sample size and power was based on the 
Mohamed 1994 study, aiming to detect a 30% reduction in intrapartum stillbirth in the Doppler 
compared to the Pinard group and this may be optimistic, necessitating a larger sample size to 
demonstrate any improved outcomes given the improved detection rates in the Doppler group.  
 
Some study limitations include that we were unable to perform secondary screening of suspected 
fetal hypoxia through the use of cardiotography; nor confirm for the presence of fetal hypoxia 
acidemia via fetal blood scalp sampling, and cord blood gases; therefore we were unable to assess 
if the identification (or lack of identification) of abnormal FHR was correlated with the presence of 
fetal hypoxia acidemia. In addition, we were unable to exclude some cases where the underlying 
cause of death was other than f tal hypoxia (e.g. congenital anomalies, early onset sepsis) due to 
diagnostic limitations in differentially diagnosing these cases. Finally, the screening process was 
all linked to the partograph which has well recognized limitations.[18]  
 
In conclusion, routine monitoring with a handheld Doppler increases the proportion of fetuses 
identified in need of prompt delivery via the identification of FHR abnormalities in labour; 
however, we did not find evidence that this lead to a decrease in the incidence of intrapartum 
stillbirth or neonatal death. While assessing user satisfaction was not the objective of this study, 
the care providers and the women expressed preference for the Doppler, and given that the Doppler 
performed no worse than the Pinard in detecting abnormal FHR or in newborn survival, this should 
be an area of further research. Finally, this study demonstrates the need for a larger study with 
linkage to rapid response for abnormal FHR, including caesarean section to ensure that increased 
detection using the Doppler leads to decreased death and disability.  
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ABSTRACT 
 
Objectives: In resource-poor settings, the standard of care to inform labour management is the 
partograph plus Pinard stethoscope for intermittent fetal heart rate (FHR) monitoring. We 
compared FHR monitoring in labour using a novel, robust wind-up handheld Doppler with the 
Pinard as a primary screening tool for abnormal FHR on perinatal outcomes.  
 
Design: Prospective equally randomised clinical trial. 
 
Setting: The labour and delivery unit of a teaching hospital in Kampala, Uganda. 
 
Participants: Of the 2042 eligible antenatal women, 1971 women in active term labour, following  
uncomplicated pregnancies were randomised to either the standard of care, or not. 
 
Intervention: Intermittent FHR monitoring using Doppler. 
 
Primary outcome measures: Incidence of FHR abnormality detection, intrapartum stillbirth and 
neonatal mortality prior to discharge. 
 
Results: Age, parity, gestational age, mode of delivery, and newborn weight were similar between 
study groups. In the Doppler group, there was a significantly higher rate of FHR abnormalities 
detected (Incidence Rate Ratio (IRR)=1.61, 95%CI 1.13 to 2.30). However, in this group there 
were also higher though not statistically significant rate of intrapartum stillbirths (IRR=3.94, 0.44 
to 35.24) and neonatal deaths (IRR=1.38, 0.44 to 4.34).   
 
Conclusion: Routine monitoring with a handheld Doppler increased the identification of FHR 
abnormalities in labour; however, our trial did not find evidence that this lead to a decrease the 
incidence of intrapartum stillbirth or neonatal death.  
 
Trial registration: ClinicalTrails.gov (1000031587) 
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TEXT BOXES 
 
1. Strengths and limitations of this study 
 
• This is the first study to use current monitoring guidelines to compare evaluated Doppler 
versus Pinard in improving stillbirth and neonatal outcomes.  
• A major strength of this study includes the prospective and randomisation design. 
• We were unable to perform secondary screening of suspected fetal hypoxia through the use 
of cardiotography; nor confirm for the presence of fetal hypoxia acidemia via fetal blood 
scalp sampling, and cord blood gases; therefore we were unable to assess if the 
identification (or lack of identification) of abnormal FHR was correlated with the presence 
of fetal hypoxia acidemia.  
• We were unable to exclude some cases where the underlying cause of death was other than 
fetal hypoxia (e.g. congenital anomalies, early onset sepsis) due to diagnostic limitations in 
differentially diagnosing these cases.  
 
 
2. Training 
 
Helping Babies Survive Labour is the training programme that was used to train the midwives in 
Nsambya hospital.  It was developed by Powerfree Education and Technology in Cape Town in 
collaboration with Save the Children and health professionals from Nsambya Hospital Kampala 
(Figure 3).  
Many training methods and guidelines are written in high income countries and are simply 
transferred for use in low income countries, although the healthcare workers in these countries 
may face very different challenges. Input was solicited from both the healthcare workers and 
academics in the target country in the preparation of these training materials.  
The material first provides a section of evidence-based theory that will help health workers to 
understand why monitoring of the fetal heart is important. This is followed by practical lessons on 
how to monitor fetal well-being, how to interpret observations and recordings and most 
importantly, gives guidelines on what to do when something is wr ng. The training is developed 
in such a way that it can be used along side the Helping Babies Breath training material, which 
focuses on neonatal resuscitation.  
 
Before this trial started, midwives and doctors were trained. Fifty-two people attended the 
training and 42 completed both the pre- and post-test. The average score for the pre-test was 
49.7% (median 50%). The average score for the post-test was 67.9% (median 69%). It does 
reveal the low baseline knowledge on appropriate intrapartum care and illustrates the need for 
continuous quality improvement.  
For link to the manual and its references 
http://www.healthynewbornnetwork.org/sites/default/files/resources/HBSL%20training%20bookle
t.pdf
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INTRODUCTION 
 
Approximately 44% of all child deaths under the age of 5 years occur in neonates (<28 days of 
age).[1] The third largest cause of neonatal mortality is intrapartum-related hypoxia (formerly 
called `birth asphyxia’) resulting in an estimated 660 000 neonatal deaths per year globally[1] and 
an additional 414,000 children who survive with disability.[2] There are also an estimated 1.02 
million intrapartum stillbirths almost all in low and middle income countries.[3] This burden is 
highest in areas of the world where the probability of quality of care at birth  is the lowest.[4] In 
order to reduce the incidence of intrapartum-related stillbirths and neonatal deaths, it is necessary 
to assess fetal well-being in labour with routine monitoring of the fetal heart rate (FHR), linked to 
rapid and effective  management with resuscitative measures or prompt delivery, and provision of 
neonatal resuscitation if needed.  
 
Characteristic FHR changes often precede brain injury via a process of progressive fetal hypoxic 
acidemia.[5] Intermittent auscultation as a primary screening tool to monitor fetal well-being is the 
recommended standard of care for women experiencing uncomplicated deliveries.[6-9] One 
method of intermittent auscultation uses the Pinard Fetal Stethoscope (Pinard), a trumpet shaped 
horn, to monitor the FHR and is widely adopted as the standard of care in resource-poor settings 
since it is low cost and does not require a power source or repairs. The difficulties posed in using a 
Pinard are generally not conducive to a busy labour ward. It requires additional time to precisely 
locate the fetal heart as the heart is only audible within a very narrow area of the woman's 
abdomen, it requires that the surrounding area be quiet in order to hear the fetal heart, the reading 
can be unreliable in obese women, and it requires the midwife to place her ear in close proximity 
to the woman's pubic area. In addition the midwife usually counts the FHR for short time, such as 
15 seconds, and multiplies to reach beats/minute, further decreasing accuracy and introducing 
arithmetic errors. The handheld Doppler ultrasound fetal heart rate monitor (Doppler) detects FHR 
and provides a steady state number per minute, as well as audible auscultation of the FHR. It 
requires a reliable power source and may need repairs, and is more costly than a Pinard. However, 
it permits the midwife to quickly locate the FHR, allows others including the mother to hear the 
FHR, permits the woman to remain in any comfortable position while being assessed, permits the 
midwife to both assess the FHR and communicate to the woman the status of her baby, and has 
been shown to be preferred by women over the use of the Pinard.[8,10] A rugged, wind-up, 
handheld Doppler fetal heart rate monitor (Doppler) developed by Power-free Education 
Technology (Pet.og.za) showed in initial field tests to be accurate and acceptable to both mother 
and midwives in low-resource settings.[11,12] It uses a hand crank to generate 2:30 minutes of use 
for every 30 seconds of cranking. 
 
While there have been several studies showing reduced intervention and no improved outcomes in 
the use of the intermittent (Pinard or Doppler) versus continuous cardiotocography (CTG) 
monitoring as the primary screening tool in uncomplicated deliveries,[6,13] there is little research 
on outcomes in intermittent monitoring comparing Doppler versus Pinard. A single study by 
Mohamed et al using a monitoring protocol of 10 minutes every half-hour found higher detection 
of FHR abnormalities and better perinatal outcomes in the intermittent auscultation Doppler group 
compared with the Pinard group.[14] 
 
We aimed to use a randomised trial design to compare the primary screening methods of FHR 
monitoring (Doppler as intervention versus Pinard as standard of care) on incidence of detection of 
FHR abnormalities, and on the incidence of intrapartum stillbirth and neonatal mortality in the first 
24 hours after delivery.  
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METHODS 
 
Study design and participants 
We undertook this randomised controlled trial at San Raphael of St. Francis Nsambya Hospital, a 
peri-urban private not-for-profit hospital in Kampala, Uganda. It is a teaching hospital that 
manages 7 500 deliveries annually. CTG and fetal blood gas sampling to support labour 
management, and epidural pain medication are not available. Oxytocin augmentation and 
Caesarean delivery rates are 40% and 20% respectively. The standard of care for intrapartum FHR 
monitoring is by intermittent auscultation using the Pinard.  
 
Women were requested to participate during an antenatal care appointment.  This consent was 
reconfirmed in labour provided that they presented in labour with a singleton pregnancy, in a 
cephalic position, at term or post-term (>37 weeks gestation). Women were excluded if they were 
already in second stage of labour upon admission or presented with a condition that, according to 
the doctor on duty, contra-indicated labouring (e.g. had a high risk pregnancy, such as 
preeclampsia or antepartum hemorrhage); if there was a diagnosis of intrauterine fetal death upon 
admission; or if the woman was admitted for an elective Caesarean delivery. Participants were 
presented with information about the study, and agreeing participants provided written consent. 
This study was approved by Sickkids Research Ethics Board, Nsambya Internal Review Board, as 
well as the Uganda National Council for Science and Technology. Registration of our protocol 
with ClinicalTrials.gov occurred before participant enrolment started, but due to an administrative 
error with our institution's Clinical Research Services Unit, the protocol was only released to the 
public after the completion of the study. Documentation from the Chair of our independent 
Research Ethics Board was provided to BMJ Open attesting to the version of the protocol 
provided to them prior to the start of enrolment. 
 
Randomisation 
Women were equally randomised to one of the two study methods using sequentially numbered, 
opaque sealed envelopes. Study participants and care providers where not blinded to the 
intervention. Data were collected from the patient's partograph and from the hospital’s routine 
neonatal mortality audit data, when applicable.  
 
Procedures 
The standard of care for intrapartum monitoring relied on partograph and FHR monitoring with 
the Pinard. Our pre-study training address deficiencies in monitoring standards (acceptable range 
for FHR, recognition of accelerations, decelerations, and change in baseline). We developed a 
training module entitled “Helping Babies Survive Labour” modeling on the “Helping Babies 
Breathe” visual materials and learning approach. The technical basis was from World Health 
Organisation (WHO) and Canadian Obstetric Society protocols.[5] All midwives and doctors 
were then given this in-service training for half a day. FHR monitoring was undertaken every 30 
minutes in first stage of labour; every 15 minutes in second stage before pushing; and every 5 
minutes in second stage when pushing and for 1 minute immediately after a contraction. The 
baseline FHR was recorded as a single number rather than a range, in the unit of beats per minute 
(bpm). The FHR rhythm (regular or irregular) and absence or presence of accelerations or 
decelerations were also documented. The maternal radial pulse was simultaneously palpated to 
differentiate it with the FHR.  
 
When FHR abnormalities are identified the standard of care would be to switch from intermittent 
auscultation to CTG. Since CTG is not available in Nsambya Hospital, any noted FHR 
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abnormalities were reported by the research midwife to the doctor on duty for assessment. 
Management following this assessment was either closer intermittent monitoring, or intra-uterine 
resuscitation with re-assessment of the FHR. Intra-uterine resuscitation consisted of maternal 
position change, administration of oxygen by mask to mother, initiation of intravenous infusion, 
discontinuation of oxytocin augmentation, and consider prompt delivery (assisted vaginal if 
imminent, otherwise by Caesarean). 
 
Outcomes 
The primary outcome measures of interest were detection of FHR abnormality in labour (defined 
below), intrapartum stillbirth, and neonatal deaths in the first 24 hours of life. Fetal heart rate 
abnormality is defined as tachycardia, bradycardia, or atypical variable, late or prolonged 
decelerations. Tachycardia and bradycardia are defined as baselines of >160 bpm and <110 bpm, 
respectively. Some features of atypical variable decelerations are abrupt fetal heart rate 
decelerations, lasting >2 minutes, slow return to baseline, or in the presence of tachycardia. Late 
decelerations are a repetitive, gradual decrease in the FHR and return to baseline, commencing 
after the onset of the contraction, and return to baseline after the end of the contraction. Prolonged 
decelerations are a decrease from baseline of >15 bpm lasting from 2-10 minutes. Secondary 
outcomes were Apgar score less than 7 at 5 minutes, admission to special care unit for intrapartum-
related complications (intrapartum hypoxia, neonatal encephalopathy, or meconium aspiration 
syndrome), diagnosis of neonatal encephalopathy (NE), and delivery by Caesarean.  A validated 
and simplified scoring method was used for grading mild, moderate and severe NE.[15,16] 
Indications for Caesarean delivery were failure to progress (as indicated by crossing of the action 
line on the partograph), abnormal FHR unresponsive to uterine resuscitation, and identification of 
malpresentation in labour (e.g. conversion from vertex to brow or mentum posterior). 
 
Statistical analysis 
Estimating that the use of the Doppler would reduce intrapartum stillbirth by 30% compared to the 
Pinard (based on the results of Mohamed et al 1994),[14] with 80% power to detect at least a 30% 
reduction in stillbirths with 95% confidence, we would need to enroll 840 participates in each of 
the two comparison groups. We added 20% to the sample size for each study arm to account for 
loss to follow-up and statistical adjustments and stratification, resulting in 1008 participants 
required for each comparison group. 
 
Data were double entered from the partograph and, where applicable, the hospital's routine 
neonatal mortality audit document. An interim analysis was conducted by the data safety and 
monitoring board at the mid-point of the data collection period. Descriptive statistics were used to 
describe the characteristics of the participants and their outcomes under each study arm.  
[17] 
We used population-averaged generalized Poisson regression modeling with robust variance to 
compare methods of FHR monitoring with Doppler versus Pinard on incidence rate ratio (IRR) of 
detection of FHR abnormalities, intrapartum stillbirth, and neonatal mortality (see Barros et al for 
details of this choice over logistic regression [17]). We conducted a sub-group analysis and 
qualitative reporting on the intrapartum stillbirths and pre-discharge neonatal deaths within 24 
hours and those fetuses with detected abnormal FHR. 
 
All analyses were conducted using Stata/SE (StataCorp. 2011. Stata Statistical Software: Release 
12. College Station, TX: StataCorp LP). 
 
Role of funding source 
The sponsor had no role in designing the study, analysing data, collecting data, interpreting the 
results, writing the report, or the decision to submit the paper for publication. The corresponding 
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author had complete access to all the data. 
 
RESULTS 
 
From July 2012 to December 2013, we screened 2042 women antenatally. Fifty-three women were 
ineligible (50 planned to deliver elsewhere, 3 planned Caesarean delivery); 2 women declined to 
participate; 1987 were enrolled (Figure 1). After assignment to a monitoring method, 8 of the 987 
in the Pinard arm were excluded from analysis (1 lost to follow up, 1 delivered before the 
partograph was started, 2 undiagnosed breech births, 4 undiagnosed multiple births); and 8 of the 
1000 in the Doppler arm were excluded (3 delivered before the partograph was started, 3 
undiagnosed breech births, 2 undiagnosed multiple births). The final study group was n=979 in the 
Pinard arm and n=992 in the Doppler arm. 
 
Of the 1971 women analyzed, the median maternal age was 26 years (IQR 24-30) (Table 1). There 
were a slightly higher though not statistically significant number of post-term women (≥42 weeks 
of gestational age) in the Doppler versus the Pinard arm (54/992 (5.4%) versus 41/979 (4.2%), 
p=0.193).  A similar proportion of women in the Doppler versus the Pinard arm were primiparous 
(395/992 (39.8%) versus 413/979 (42.2%)), with similar median gestational age (39 weeks, IQR 
38-40), and similar median newborn weight (3300g, IQR 3000-3500g).  
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Table 1: Demographic, clinical and perinatal characteristics 
 
  Pinard (n=979) Doppler (n=992) p-value 
Maternal age (years) Median (IQR) 26 (23-30) 27 (24-30) 0.95 
Marital status Married 816 (83.4) 818 (82.5) 0.60 
 Single 163 (16.7) 174 (17.5)  
Maternal education None 9 (0.9) 7 (0.7) 0.62 
 Primary 93 (9.5) 94 (9.5)  
 Secondary 385 (39.3) 423 (42.6)  
 Vocational 235 (24.0) 224 (22.6)  
 University 257 (26.3) 243 (24.5)  
 Missing  1 (0.1)  
Maternal occupation Housewife 357 (36.5) 377 (38.0) 0.80 
 Skilled worker 84 (8.6) 75 (7.6)  
 Self-employed 271 (27.7) 260 (26.2)  
 Professional 252 (25.7) 262 (26.4)  
 Other 15 (1.5) 18 (1.8)  
No. of ANC visits Median (IQR) 4 (3-5) 4 (3-5) 0.58 
Complication noted in 
pregnancy Yes 17 (98.3) 24 (2.4) 0.29 
 No 962 (1.7) 968 (97.6)  
Gravity 1 334 (34.1) 332 (33.5) 0.64 
 2 422 (43.1) 416 (41.9)  
 ≥3 223 (22.8) 244 (24.6)  
Parity 0 413 (42.2) 395 (39.8) 0.31 
 1 238 (24.3) 232 (23.4)  
 ≥2 328 (33.5) 365 (36.8)  
Previous perinatal death Yes 24 (2.5) 29 (2.9) 0.52 
 No 955 (97.6) 963 (97.1)  
Malarial IPTp Yes 914 (93.4) 923 (93.0) 0.78 
 No 65 (6.6) 69 (7.0)  
Syphilis Negative 830 (84.8) 869 (87.6) 0.14 
 Positive 11 (1.1) 6 (0.6)  
 Missing 138 (14.1) 117 (11.8)  
HIV Status Negative 887 (90.6) 892 (89.9) 0.55 
 Positive 46 (4.7) 57 (5.6)  
 Missing 46 (4.7) 43 (4.3)  
Gestational age at 
delivery (weeks) Median (IQR) 39 (38-40) 39 (38-40) 0.80 
Postterm gestation (≥42 
weeks) Yes 41 (4.2) 54 (5.4) 0.19 
 No 938 (95.8) 938 (94.6)  
Newborn weight (g) Median (IQR) 3300 (3000-3500) 3300 (3000-3500) 0.70 
Data are n (%) or median (IQR); IPTp - Intermittent preventative treatment in pregnancy; HIV - Human 
immunodeficiency virus 
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There were no differences between the study arms in Apgar score <7 at 5 minutes (23 (2.3%) in 
the Doppler versus 17(1.7%)  the Painard, p=0.40) or admission to neonatal intensive care unit for 
any reason (48(4.8%) in the Doppler versus 36(3.7%) the Pinard, p=0.20). Similar proportions of 
women in the Doppler versus Pinard arm had Caesarean deliveries (175/992 (17.6%) versus 
166/979 (17.0%), p=0.695).  
 
There were a significantly higher number of FHR abnormalities detected in the Doppler versus 
Pinard arm (75/992 (7.6%) versus 46/979 (4.7%), p=0.008, IRR=1.61, 95%CI 1.13-2.30) (Table 
2). There were a higher though not statistically significant number of intrapartum stillbirths in the 
Doppler versus Pinard arm (4/988 (0.4%) versus 1/977 (0.1%), p=0.184, IRR=3.94, 95%CI 0.44-
35.24), and higher number of neonatal deaths prior to discharge (7/985 (0.7%) versus 5//973 
(0.5%), p=0.579, IRR=1.38, 95%CI 0.44-4.34).  
 
There were 121 cases of abnormal FHR detected in labour (Figure 2). Of the 17 deaths in total 
(intrapartum stillbirths and neonatal deaths prior to discharge), 5 were associated with the detection 
of abnormal FHR in labour. In a subgroup analysis of those cases where abnormal FHR was 
detected, there were a higher though not statistically significant proportion of deaths in the Doppler 
versus Pinard arm (4/71 (5.3%) vs 1/45 (2.2%), IRR=2.45 95%CI 0.28-21.47). The remaining 12 
deaths who had a normal FHR reported; 3 had missing cause of death, and 1 had a congenital 
anomaly, and cause of death for the remaining 8 was intrauterine hypoxia, respiratory distress, or 
neonatal encephalopathy, suggesting that an abnormal FHR was a missed diagnosis in labour for 
these 8 deaths.  
 
Table 23: Primary outcomes by treatment group 
    
Pinard 
(n=979) 
Doppler 
(n=992) p value  IRR
*
 (95% CI) p value 
Abnormality 
detected Yes 46 (4.7) 75 (7.6) 0.008 1.61 (1.13 to 2.30) 0.009 
 No 933 (95.3) 917 (92.4)    
Intrapartum 
stillbirth Yes 1 (0.1) 4 (0.4) 0.184 3.94
**
 (0.44 to 35.24) 0.219 
 No 977 (99.9) 988 (99.6)    
 Missing 1 0    
        
Neonatal death 
prior to discharge Yes 5 (0.5) 7 (0.7) 0.579 1.38
**
 (0.44 to 4.34) 0.552 
 No 973 (99.5) 985 (99.3)    
 Missing 1     
IRR - incidence rate ratio; 
*
not adjusted, significant baseline characteristics (p value <0.2) were tested and 
did not influence measure of effect in the model 
**
excludes missing from analysis 
 
DISCUSSION 
 
Detection of abnormal FHR in labour is essential for identifying the fetus in need of responsive 
management such as prompt delivery. We report that intermittent auscultation with a Doppler 
identifies 60% more in need of prompt delivery (IRR=1.61); however, we did not find that this 
identification resulted in a significant decrease in mortality, although one would expect that higher 
Page 21 of 29
For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml
BMJ Open
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For peer review only
 10
detection should lead to prompt delivery and improved outcomes.  
 
We propose a number of explanations for this lack of detected impact. We considered that there 
may have been a learning curve for staff using the Doppler as a new technology; however, we 
found no difference in outcomes over time or between groups (data not shown). Secondly, it is 
possible that use of technology such as the Doppler lead to false reassurance that FHR was being 
closely monitored, delayed involvement of senior staff and subsequent delivery, or there may 
simply have been delay between recognition and action that, by chance, had more deleterious 
effects in the intervention group. Thirdly this study sample size and power was based on the 
Mohamed 1994 study, aiming to detect a 30% reduction in intrapartum stillbirth in the Doppler 
compared to the Pinard group and this may be optimistic, necessitating a larger sample size to 
demonstrate any improved outcomes given the improved detection rates in the Doppler group.  
 
Some study limitations include that we were unable to perform secondary screening of suspected 
fetal hypoxia through the use of cardiotography; nor confirm for the presence of fetal hypoxia 
acidemia via fetal blood scalp sampling, and cord blood gases; therefore we were unable to assess 
if the identification (or lack of identification) of abnormal FHR was correlated with the presence of 
fetal hypoxia acidemia. In addition, we were unable to exclude some cases where the underlying 
cause of death was other than f tal hypoxia (e.g. congenital anomalies, early onset sepsis) due to 
diagnostic limitations in differentially diagnosing these cases. Finally, the screening process was 
all linked to the partograph which has well recognized limitations.[18]  
 
In conclusion, routine monitoring with a handheld Doppler increases the proportion of fetuses 
identified in need of prompt delivery via the identification of FHR abnormalities in labour; 
The care providers and the women expressed preferences for the Doppler, however, we did not 
find evidence that this lead to a decrease in the incidence of intrapartum stillbirth or neonatal death. 
While assessing user satisfaction was not the objective of this study, the care providers and the 
women expressed preference for the Doppler, and given that the Doppler performed no worse than 
the Pinard in detecting abnormal FHR or in newborn survival, this should be an area of further 
research. Finally, tThis study demonstrates the need for a further larger study with linkage to rapid 
response for abnormal FHR, including caesarean section to ensure that increased detection using 
the Doppler leads to decreased death and disability.  
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Figure 2: Flow diagram for outcome by fetal heart rate and management   
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CONSORT 2010 checklist of information to include when reporting a randomised trial* 
 
Section/Topic 
Item 
No Checklist item 
Reported 
on page No 
Title and abstract 
 1a Identification as a randomised trial in the title 1 
1b Structured summary of trial design, methods, results, and conclusions (for specific guidance see CONSORT for abstracts) 2 
Introduction 
Background and 
objectives 
2a Scientific background and explanation of rationale 4 
2b Specific objectives or hypotheses 4 
Methods 
Trial design 3a Description of trial design (such as parallel, factorial) including allocation ratio 5 
3b Important changes to methods after trial commencement (such as eligibility criteria), with reasons not applicable 
Participants 4a Eligibility criteria for participants 5 
4b Settings and locations where the data were collected 5 
Interventions 5 The interventions for each group with sufficient details to allow replication, including how and when they were 
actually administered 
5 
Outcomes 6a Completely defined pre-specified primary and secondary outcome measures, including how and when they 
were assessed 
6 
6b Any changes to trial outcomes after the trial commenced, with reasons not applicable 
Sample size 7a How sample size was determined 6 
7b When applicable, explanation of any interim analyses and stopping guidelines 6 
Randomisation:    
 Sequence 
generation 
8a Method used to generate the random allocation sequence not reported 
8b Type of randomisation; details of any restriction (such as blocking and block size) 5 
 Allocation 
concealment 
mechanism 
9 Mechanism used to implement the random allocation sequence (such as sequentially numbered containers), 
describing any steps taken to conceal the sequence until interventions were assigned 
5 
 Implementation 10 Who generated the random allocation sequence, who enrolled participants, and who assigned participants to 
interventions 
5 
Blinding 11a If done, who was blinded after assignment to interventions (for example, participants, care providers, those 5 
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assessing outcomes) and how 
11b If relevant, description of the similarity of interventions 5 
Statistical methods 12a Statistical methods used to compare groups for primary and secondary outcomes 6 
12b Methods for additional analyses, such as subgroup analyses and adjusted analyses 6 
Results 
Participant flow (a 
diagram is strongly 
recommended) 
13a For each group, the numbers of participants who were randomly assigned, received intended treatment, and 
were analysed for the primary outcome 
Figure 1, 6-7 
13b For each group, losses and exclusions after randomisation, together with reasons Figure 1, 6-7 
Recruitment 14a Dates defining the periods of recruitment and follow-up 6 
14b Why the trial ended or was stopped 6 
Baseline data 15 A table showing baseline demographic and clinical characteristics for each group 8 
Numbers analysed 16 For each group, number of participants (denominator) included in each analysis and whether the analysis was 
by original assigned groups 
8 
Outcomes and 
estimation 
17a For each primary and secondary outcome, results for each group, and the estimated effect size and its 
precision (such as 95% confidence interval) 
10 
17b For binary outcomes, presentation of both absolute and relative effect sizes is recommended 10 
Ancillary analyses 18 Results of any other analyses performed, including subgroup analyses and adjusted analyses, distinguishing 
pre-specified from exploratory 
9 
Harms 19 All important harms or unintended effects in each group (for specific guidance see CONSORT for harms) Table 2, 9 
Discussion 
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, multiplicity of analyses 10 
Generalisability 21 Generalisability (external validity, applicability) of the trial findings 10 
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and considering other relevant evidence 10 
Other information  
Registration 23 Registration number and name of trial registry 2 
Protocol 24 Where the full trial protocol can be accessed, if available 2 
Funding 25 Sources of funding and other support (such as supply of drugs), role of funders 2 
 
*We strongly recommend reading this statement in conjunction with the CONSORT 2010 Explanation and Elaboration for important clarifications on all the items. If relevant, we also 
recommend reading CONSORT extensions for cluster randomised trials, non-inferiority and equivalence trials, non-pharmacological treatments, herbal interventions, and pragmatic trials. 
Additional extensions are forthcoming: for those and for up to date references relevant to this checklist, see www.consort-statement.org. 
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ABSTRACT 
 
Objectives: In resource-poor settings, the standard of care to inform labour management is the 
partograph plus Pinard stethoscope for intermittent fetal heart rate (FHR) monitoring. We 
compared FHR monitoring in labour using a novel, robust wind-up handheld Doppler with the 
Pinard as a primary screening tool for abnormal FHR on perinatal outcomes.  
 
Design: Prospective equally randomised clinical trial. 
 
Setting: The labour and delivery unit of a teaching hospital in Kampala, Uganda. 
 
Participants: Of the 2042 eligible antenatal women, 1971 women in active term labour, following  
uncomplicated pregnancies were randomised to either the standard of care, or not. 
 
Intervention: Intermittent FHR monitoring using Doppler. 
 
Primary outcome measures: Incidence of FHR abnormality detection, intrapartum stillbirth and 
neonatal mortality prior to discharge. 
 
Results: Age, parity, gestational age, mode of delivery, and newborn weight were similar between 
study groups. In the Doppler group, there was a significantly higher rate of FHR abnormalities 
detected (Incidence Rate Ratio (IRR)=1.61, 95%CI 1.13 to 2.30). However, in this group there 
were also higher though not statistically significant rate of intrapartum stillbirths (IRR=3.94, 0.44 
to 35.24) and neonatal deaths (IRR=1.38, 0.44 to 4.34).   
 
Conclusion: Routine monitoring with a handheld Doppler increased the identification of FHR 
abnormalities in labour; however, our trial did not find evidence that this lead to a decrease the 
incidence of intrapartum stillbirth or neonatal death.  
 
Trial registration: ClinicalTrails.gov (1000031587) 
Page 2 of 29
For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml
BMJ Open
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For peer review only
 3 
TEXT BOXES 
 
1. Strengths and limitations of this study 
 
• This is the first study to use current monitoring guidelines to compare evaluated Doppler 
versus Pinard in improving stillbirth and neonatal outcomes.  
• A major strength of this study includes the prospective and randomisation design. 
• We were unable to perform secondary screening of suspected fetal hypoxia through the use 
of cardiotography; nor confirm for the presence of fetal hypoxia acidemia via fetal blood 
scalp sampling, and cord blood gases; therefore we were unable to assess if the 
identification (or lack of identification) of abnormal FHR was correlated with the presence 
of fetal hypoxia acidemia.  
• We were unable to exclude some cases where the underlying cause of death was other than 
fetal hypoxia (e.g. congenital anomalies, early onset sepsis) due to diagnostic limitations in 
differentially diagnosing these cases.  
 
 
2. Training 
 
Helping Babies Survive Labour is the training programme that was used to train the midwives in 
Nsambya hospital.  It was developed by Powerfree Education and Technology in Cape Town in 
collaboration with Save the Children and health professionals from Nsambya Hospital Kampala 
(Figure 3).  
Many training methods and guidelines are written in high income countries and are simply 
transferred for use in low income countries, although the healthcare workers in these countries 
may face very different challenges. Input was solicited from both the healthcare workers and 
academics in the target country in the preparation of these training materials.  
The material first provides a section of evidence-based theory that will help health workers to 
understand why monitoring of the fetal heart is important. This is followed by practical lessons on 
how to monitor fetal well-being, how to interpret observations and recordings and most 
importantly, gives guidelines on what to do when something is wr ng. The training is developed 
in such a way that it can be used along side the Helping Babies Breath training material, which 
focuses on neonatal resuscitation.  
 
Before this trial started, midwives and doctors were trained. Fifty-two people attended the 
training and 42 completed both the pre- and post-test. The average score for the pre-test was 
49.7% (median 50%). The average score for the post-test was 67.9% (median 69%). It does 
reveal the low baseline knowledge on appropriate intrapartum care and illustrates the need for 
continuous quality improvement.  
For link to the manual and its references 
http://www.healthynewbornnetwork.org/sites/default/files/resources/HBSL%20training%20bookle
t.pdf
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INTRODUCTION 
 
Approximately 44% of all child deaths under the age of 5 years occur in neonates (<28 days of 
age).[1] The third largest cause of neonatal mortality is intrapartum-related hypoxia (formerly 
called `birth asphyxia’) resulting in an estimated 660 000 neonatal deaths per year globally[1] and 
an additional 414,000 children who survive with disability.[2] There are also an estimated 1.02 
million intrapartum stillbirths almost all in low and middle income countries.[3] This burden is 
highest in areas of the world where the probability of quality of care at birth  is the lowest.[4] In 
order to reduce the incidence of intrapartum-related stillbirths and neonatal deaths, it is necessary 
to assess fetal well-being in labour with routine monitoring of the fetal heart rate (FHR), linked to 
rapid and effective  management with resuscitative measures or prompt delivery, and provision of 
neonatal resuscitation if needed.  
 
Characteristic FHR changes often precede brain injury via a process of progressive fetal hypoxic 
acidemia.[5] Intermittent auscultation as a primary screening tool to monitor fetal well-being is the 
recommended standard of care for women experiencing uncomplicated deliveries.[6-9] One 
method of intermittent auscultation uses the Pinard Fetal Stethoscope (Pinard), a trumpet shaped 
horn, to monitor the FHR and is widely adopted as the standard of care in resource-poor settings 
since it is low cost and does not require a power source or repairs. The difficulties posed in using a 
Pinard are generally not conducive to a busy labour ward. It requires additional time to precisely 
locate the fetal heart as the heart is only audible within a very narrow area of the woman's 
abdomen, it requires that the surrounding area be quiet in order to hear the fetal heart, the reading 
can be unreliable in obese women, and it requires the midwife to place her ear in close proximity 
to the woman's pubic area. In addition the midwife usually counts the FHR for short time, such as 
15 seconds, and multiplies to reach beats/minute, further decreasing accuracy and introducing 
arithmetic errors. The handheld Doppler ultrasound fetal heart rate monitor (Doppler) detects FHR 
and provides a steady state number per minute, as well as audible auscultation of the FHR. It 
requires a reliable power source and may need repairs, and is more costly than a Pinard. However, 
it permits the midwife to quickly locate the FHR, allows others including the mother to hear the 
FHR, permits the woman to remain in any comfortable position while being assessed, permits the 
midwife to both assess the FHR and communicate to the woman the status of her baby, and has 
been shown to be preferred by women over the use of the Pinard.[8,10] A rugged, wind-up, 
handheld Doppler fetal heart rate monitor (Doppler) developed by Power-free Education 
Technology (Pet.og.za) showed in initial field tests to be accurate and acceptable to both mother 
and midwives in low-resource settings.[11,12] It uses a hand crank to generate 2:30 minutes of use 
for every 30 seconds of cranking. 
 
While there have been several studies showing reduced intervention and no improved outcomes in 
the use of the intermittent (Pinard or Doppler) versus continuous cardiotocography (CTG) 
monitoring as the primary screening tool in uncomplicated deliveries,[6,13] there is little research 
on outcomes in intermittent monitoring comparing Doppler versus Pinard. A single study by 
Mohamed et al using a monitoring protocol of 10 minutes every half-hour found higher detection 
of FHR abnormalities and better perinatal outcomes in the intermittent auscultation Doppler group 
compared with the Pinard group.[14] 
 
We aimed to use a randomised trial design to compare the primary screening methods of FHR 
monitoring (Doppler as intervention versus Pinard as standard of care) on incidence of detection of 
FHR abnormalities, and on the incidence of intrapartum stillbirth and neonatal mortality in the first 
24 hours after delivery.  
Page 4 of 29
For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml
BMJ Open
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For peer review only
 5 
 
 
METHODS 
 
Study design and participants 
We undertook this randomised controlled trial at San Raphael of St. Francis Nsambya Hospital, a 
peri-urban private not-for-profit hospital in Kampala, Uganda. It is a teaching hospital that 
manages 7 500 deliveries annually. CTG and fetal blood gas sampling to support labour 
management, and epidural pain medication are not available. Oxytocin augmentation and 
Caesarean delivery rates are 40% and 20% respectively. The standard of care for intrapartum FHR 
monitoring is by intermittent auscultation using the Pinard.  
 
Women were requested to participate during an antenatal care appointment.  This consent was 
reconfirmed in labour provided that they presented in labour with a singleton pregnancy, in a 
cephalic position, at term or post-term (>37 weeks gestation). Women were excluded if they were 
already in second stage of labour upon admission or presented with a condition that, according to 
the doctor on duty, contra-indicated labouring (e.g. antepartum hemorrhage); if there was a 
diagnosis of intrauterine fetal death upon admission; or if the woman was admitted for an elective 
Caesarean delivery. Participants were presented with information about the study, and agreeing 
participants provided written consent. This study was approved by Sickkids Research Ethics 
Board, Nsambya Internal Review Board, as well as the Uganda National Council for Science and 
Technology. Registration of our protocol with ClinicalTrials.gov occurred before 
participant enrolment started, but due to an administrative error with our institution's Clinical 
Research Services Unit, the protocol was only released to the public after the completion of the 
study. Documentation from the Chair of our independent Research Ethics Board was provided to 
BMJ Open attesting to the version of the protocol provided to them prior to the start of enrolment. 
 
Randomisation 
Women were equally randomised to one of the two study methods using sequentially numbered, 
opaque sealed envelopes. Study participants and care providers where not blinded to the 
intervention. Data were collected from the patient's partograph and from the hospital’s routine 
neonatal mortality audit data, when applicable.  
 
Procedures 
The standard of care for intrapartum monitoring relied on partograph and FHR monitoring with 
the Pinard. Our pre-study training address deficiencies in monitoring standards (acceptable range 
for FHR, recognition of accelerations, decelerations, and change in baseline). We developed a 
training module entitled “Helping Babies Survive Labour” modeling on the “Helping Babies 
Breathe” visual materials and learning approach. The technical basis was from World Health 
Organisation (WHO) and Canadian Obstetric Society protocols.[5] All midwives and doctors 
were then given this in-service training for half a day. FHR monitoring was undertaken every 30 
minutes in first stage of labour; every 15 minutes in second stage before pushing; and every 5 
minutes in second stage when pushing and for 1 minute immediately after a contraction. The 
baseline FHR was recorded as a single number rather than a range, in the unit of beats per minute 
(bpm). The FHR rhythm (regular or irregular) and absence or presence of accelerations or 
decelerations were also documented. The maternal radial pulse was simultaneously palpated to 
differentiate it with the FHR.  
 
When FHR abnormalities are identified the standard of care would be to switch from intermittent 
auscultation to CTG. Since CTG is not available in Nsambya Hospital, any noted FHR 
abnormalities were reported by the research midwife to the doctor on duty for assessment. 
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Management following this assessment was either closer intermittent monitoring, or intra-uterine 
resuscitation with re-assessment of the FHR. Intra-uterine resuscitation consisted of maternal 
position change, administration of oxygen by mask to mother, initiation of intravenous infusion, 
discontinuation of oxytocin augmentation, and consider prompt delivery (assisted vaginal if 
imminent, otherwise by Caesarean). 
 
Outcomes 
The primary outcome measures of interest were detection of FHR abnormality in labour (defined 
below), intrapartum stillbirth, and neonatal deaths in the first 24 hours of life. Fetal heart rate 
abnormality is defined as tachycardia, bradycardia, or atypical variable, late or prolonged 
decelerations. Tachycardia and bradycardia are defined as baselines of >160 bpm and <110 bpm, 
respectively. Some features of atypical variable decelerations are abrupt fetal heart rate 
decelerations, lasting >2 minutes, slow return to baseline, or in the presence of tachycardia. Late 
decelerations are a repetitive, gradual decrease in the FHR and return to baseline, commencing 
after the onset of the contraction, and return to baseline after the end of the contraction. Prolonged 
decelerations are a decrease from baseline of >15 bpm lasting from 2-10 minutes. Secondary 
outcomes were Apgar score less than 7 at 5 minutes, admission to special care unit for intrapartum-
related complications (intrapartum hypoxia, neonatal encephalopathy, or meconium aspiration 
syndrome), diagnosis of neonatal encephalopathy (NE), and delivery by Caesarean.  A validated 
and simplified scoring method was used for grading mild, moderate and severe NE.[15,16] 
Indications for Caesarean delivery were failure to progress (as indicated by crossing of the action 
line on the partograph), abnormal FHR unresponsive to uterine resuscitation, and identification of 
malpresentation in labour (e.g. conversion from vertex to brow or mentum posterior). 
 
Statistical analysis 
Estimating that the use of the Doppler would reduce intrapartum stillbirth by 30% compared to the 
Pinard (based on the results of Mohamed et al 1994),[14] with 80% power to detect at least a 30% 
reduction in stillbirths with 95% confidence, we would need to enroll 840 participates in each of 
the two comparison groups. We added 20% to the sample size for each study arm to account for 
loss to follow-up and statistical adjustments and stratification, resulting in 1008 participants 
required for each comparison group. 
 
Data were double entered from the partograph and, where applicable, the hospital's routine 
neonatal mortality audit document. An interim analysis was conducted by the data safety and 
monitoring board at the mid-point of the data collection period. Descriptive statistics were used to 
describe the characteristics of the participants and their outcomes under each study arm.  
We used population-averaged generalized Poisson regression modeling with robust variance to 
compare methods of FHR monitoring with Doppler versus Pinard on incidence rate ratio (IRR) of 
detection of FHR abnormalities, intrapartum stillbirth, and neonatal mortalit  (see Barros et al for 
details of this choice over logistic regression [17]). We conducted a sub-group analysis and 
qualitative reporting on the intrapartum stillbirths and pre-discharge neonatal deaths within 24 
hours and those fetuses with detected abnormal FHR. 
 
All analyses were conducted using Stata/SE (StataCorp. 2011. Stata Statistical Software: Release 
12. College Station, TX: StataCorp LP). 
 
Role of funding source 
The sponsor had no role in designing the study, analysing data, collecting data, interpreting the 
results, writing the report, or the decision to submit the paper for publication. The corresponding 
author had complete access to all the data. 
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RESULTS 
 
From July 2012 to December 2013, we screened 2042 women antenatally. Fifty-three women were 
ineligible (50 planned to deliver elsewhere, 3 planned Caesarean delivery); 2 women declined to 
participate; 1987 were enrolled (Figure 1). After assignment to a monitoring method, 8 of the 987 
in the Pinard arm were excluded from analysis (1 lost to follow up, 1 delivered before the 
partograph was started, 2 undiagnosed breech births, 4 undiagnosed multiple births); and 8 of the 
1000 in the Doppler arm were excluded (3 delivered before the partograph was started, 3 
undiagnosed breech births, 2 undiagnosed multiple births). The final study group was n=979 in the 
Pinard arm and n=992 in the Doppler arm. 
 
Of the 1971 women analyzed, the median maternal age was 26 years (IQR 24-30) (Table 1). There 
were a slightly higher though not statistically significant number of post-term women (≥42 weeks 
of gestational age) in the Doppler versus the Pinard arm (54/992 (5.4%) versus 41/979 (4.2%), 
p=0.193).  A similar proportion of women in the Doppler versus the Pinard arm were primiparous 
(395/992 (39.8%) versus 413/979 (42.2%)), with similar median gestational age (39 weeks, IQR 
38-40), and similar median newborn weight (3300g, IQR 3000-3500g).  
Page 7 of 29
For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml
BMJ Open
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For peer review only
 8 
 
 
Table 1: Demographic, clinical and perinatal characteristics 
 
  Pinard (n=979) Doppler (n=992) p-value 
Maternal age (years) Median (IQR) 26 (23-30) 27 (24-30) 0.95 
Marital status Married 816 (83.4) 818 (82.5) 0.60 
 Single 163 (16.7) 174 (17.5)  
Maternal education None 9 (0.9) 7 (0.7) 0.62 
 Primary 93 (9.5) 94 (9.5)  
 Secondary 385 (39.3) 423 (42.6)  
 Vocational 235 (24.0) 224 (22.6)  
 University 257 (26.3) 243 (24.5)  
 Missing  1 (0.1)  
Maternal occupation Housewife 357 (36.5) 377 (38.0) 0.80 
 Skilled worker 84 (8.6) 75 (7.6)  
 Self-employed 271 (27.7) 260 (26.2)  
 Professional 252 (25.7) 262 (26.4)  
 Other 15 (1.5) 18 (1.8)  
No. of ANC visits Median (IQR) 4 (3-5) 4 (3-5) 0.58 
Complication noted in 
pregnancy Yes 17 (98.3) 24 (2.4) 0.29 
 No 962 (1.7) 968 (97.6)  
Gravity 1 334 (34.1) 332 (33.5) 0.64 
 2 422 (43.1) 416 (41.9)  
 ≥3 223 (22.8) 244 (24.6)  
Parity 0 413 (42.2) 395 (39.8) 0.31 
 1 238 (24.3) 232 (23.4)  
 ≥2 328 (33.5) 365 (36.8)  
Previous perinatal death Yes 24 (2.5) 29 (2.9) 0.52 
 No 955 (97.6) 963 (97.1)  
Malarial IPTp Yes 914 (93.4) 923 (93.0) 0.78 
 No 65 (6.6) 69 (7.0)  
Syphilis Negative 830 (84.8) 869 (87.6) 0.14 
 Positive 11 (1.1) 6 (0.6)  
 Missing 138 (14.1) 117 (11.8)  
HIV Status Negative 887 (90.6) 892 (89.9) 0.55 
 Positive 46 (4.7) 57 (5.6)  
 Missing 46 (4.7) 43 (4.3)  
Gestational age at 
delivery (weeks) Median (IQR) 39 (38-40) 39 (38-40) 0.80 
Postterm gestation (≥42 
weeks) Yes 41 (4.2) 54 (5.4) 0.19 
 No 938 (95.8) 938 (94.6)  
Newborn weight (g) Median (IQR) 3300 (3000-3500) 3300 (3000-3500) 0.70 
Data are n (%) or median (IQR); IPTp - Intermittent preventative treatment in pregnancy; HIV - Human 
immunodeficiency virus 
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There were no differences between the study arms in Apgar score <7 at 5 minutes (23 (2.3%) in 
the Doppler versus 17(1.7%)  the Painard, p=0.40) or admission to neonatal intensive care unit for 
any reason (48(4.8%) in the Doppler versus 36(3.7%) the Pinard, p=0.20). Similar proportions of 
women in the Doppler versus Pinard arm had Caesarean deliveries (175/992 (17.6%) versus 
166/979 (17.0%), p=0.695).  
 
There were a significantly higher number of FHR abnormalities detected in the Doppler versus 
Pinard arm (75/992 (7.6%) versus 46/979 (4.7%), p=0.008, IRR=1.61, 95%CI 1.13-2.30) (Table 
2). There were a higher though not statistically significant number of intrapartum stillbirths in the 
Doppler versus Pinard arm (4/988 (0.4%) versus 1/977 (0.1%), p=0.184, IRR=3.94, 95%CI 0.44-
35.24), and higher number of neonatal deaths prior to discharge (7/985 (0.7%) versus 5//973 
(0.5%), p=0.579, IRR=1.38, 95%CI 0.44-4.34).  
 
There were 121 cases of abnormal FHR detected in labour (Figure 2). Of the 17 deaths in total 
(intrapartum stillbirths and neonatal deaths prior to discharge), 5 were associated with the detection 
of abnormal FHR in labour. In a subgroup analysis of those cases where abnormal FHR was 
detected, there were a higher though not statistically significant proportion of deaths in the Doppler 
versus Pinard arm (4/71 (5.3%) vs 1/45 (2.2%), IRR=2.45 95%CI 0.28-21.47). The remaining 12 
deaths who had a normal FHR reported; 3 had missing cause of death, and 1 had a congenital 
anomaly, and cause of death for the remaining 8 was intrauterine hypoxia, respiratory distress, or 
neonatal encephalopathy, suggesting that an abnormal FHR was a missed diagnosis in labour for 
these 8 deaths.  
 
Table 2: Primary outcomes by treatment group 
    
Pinard 
(n=979) 
Doppler 
(n=992) p value  IRR
*
 (95% CI) p value 
Abnormality 
detected Yes 46 (4.7) 75 (7.6) 0.008 1.61 (1.13 to 2.30) 0.009 
 No 933 (95.3) 917 (92.4)    
Intrapartum 
stillbirth Yes 1 (0.1) 4 (0.4) 0.184 3.94
**
 (0.44 to 35.24) 0.219 
 No 977 (99.9) 988 (99.6)    
 Missing 1 0    
        
Neonatal death 
prior to discharge Yes 5 (0.5) 7 (0.7) 0.579 1.38
**
 (0.44 to 4.34) 0.552 
 No 973 (99.5) 985 (99.3)    
 Missing 1     
IRR - incidence rate ratio; 
*
not adjusted, significant baseline characteristics (p value <0.2) were tested and 
did not influence measure of effect in the model 
**
excludes missing from analysis 
 
DISCUSSION 
 
Detection of abnormal FHR in labour is essential for identifying the fetus in need of responsive 
management such as prompt delivery. We report that intermittent auscultation with a Doppler 
identifies 60% more in need of prompt delivery (IRR=1.61); however, we did not find that this 
identification resulted in a significant decrease in mortality, although one would expect that higher 
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detection should lead to prompt delivery and improved outcomes.  
 
We propose a number of explanations for this lack of detected impact. We considered that there 
may have been a learning curve for staff using the Doppler as a new technology; however, we 
found no difference in outcomes over time or between groups (data not shown). Secondly, it is 
possible that use of technology such as the Doppler lead to false reassurance that FHR was being 
closely monitored, delayed involvement of senior staff and subsequent delivery, or there may 
simply have been delay between recognition and action that, by chance, had more deleterious 
effects in the intervention group. Thirdly this study sample size and power was based on the 
Mohamed 1994 study, aiming to detect a 30% reduction in intrapartum stillbirth in the Doppler 
compared to the Pinard group and this may be optimistic, necessitating a larger sample size to 
demonstrate any improved outcomes given the improved detection rates in the Doppler group.  
 
Some study limitations include that we were unable to perform secondary screening of suspected 
fetal hypoxia through the use of cardiotography; nor confirm for the presence of fetal hypoxia 
acidemia via fetal blood scalp sampling, and cord blood gases; therefore we were unable to assess 
if the identification (or lack of identification) of abnormal FHR was correlated with the presence of 
fetal hypoxia acidemia. In addition, we were unable to exclude some cases where the underlying 
cause of death was other than f tal hypoxia (e.g. congenital anomalies, early onset sepsis) due to 
diagnostic limitations in differentially diagnosing these cases. Finally, the screening process was 
all linked to the partograph which has well recognized limitations.[18]  
 
In conclusion, routine monitoring with a handheld Doppler increases the proportion of fetuses 
identified in need of prompt delivery via the identification of FHR abnormalities in labour; 
however, we did not find evidence that this lead to a decrease in the incidence of intrapartum 
stillbirth or neonatal death. While assessing user satisfaction was not the objective of this study, 
the care providers and the women expressed preference for the Doppler, and given that the Doppler 
performed no worse than the Pinard in detecting abnormal FHR or in newborn survival, this should 
be an area of further research. Finally, this study demonstrates the need for a larger study with 
linkage to rapid response for abnormal FHR, including caesarean section to ensure that increased 
detection using the Doppler leads to decreased death and disability.  
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ABSTRACT 
 
Objectives: In resource-poor settings, the standard of care to inform labour management is the 
partograph plus Pinard stethoscope for intermittent fetal heart rate (FHR) monitoring. We 
compared FHR monitoring in labour using a novel, robust wind-up handheld Doppler with the 
Pinard as a primary screening tool for abnormal FHR on perinatal outcomes.  
 
Design: Prospective equally randomised clinical trial. 
 
Setting: The labour and delivery unit of a teaching hospital in Kampala, Uganda. 
 
Participants: Of the 2042 eligible antenatal women, 1971 women in active term labour, following  
uncomplicated pregnancies were randomised to either the standard of care, or not. 
 
Intervention: Intermittent FHR monitoring using Doppler. 
 
Primary outcome measures: Incidence of FHR abnormality detection, intrapartum stillbirth and 
neonatal mortality prior to discharge. 
 
Results: Age, parity, gestational age, mode of delivery, and newborn weight were similar between 
study groups. In the Doppler group, there was a significantly higher rate of FHR abnormalities 
detected (Incidence Rate Ratio (IRR)=1.61, 95%CI 1.13 to 2.30). However, in this group there 
were also higher though not statistically significant rate of intrapartum stillbirths (IRR=3.94, 0.44 
to 35.24) and neonatal deaths (IRR=1.38, 0.44 to 4.34).   
 
Conclusion: Routine monitoring with a handheld Doppler increased the identification of FHR 
abnormalities in labour; however, our trial did not find evidence that this lead to a decrease the 
incidence of intrapartum stillbirth or neonatal death.  
 
Trial registration: ClinicalTrails.gov (1000031587) 
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TEXT BOXES 
 
1. Strengths and limitations of this study 
 
• This is the first study to use current monitoring guidelines to compare evaluated Doppler 
versus Pinard in improving stillbirth and neonatal outcomes.  
• A major strength of this study includes the prospective and randomisation design. 
• We were unable to perform secondary screening of suspected fetal hypoxia through the use 
of cardiotography; nor confirm for the presence of fetal hypoxia acidemia via fetal blood 
scalp sampling, and cord blood gases; therefore we were unable to assess if the 
identification (or lack of identification) of abnormal FHR was correlated with the presence 
of fetal hypoxia acidemia.  
• We were unable to exclude some cases where the underlying cause of death was other than 
fetal hypoxia (e.g. congenital anomalies, early onset sepsis) due to diagnostic limitations in 
differentially diagnosing these cases.  
 
 
2. Training 
 
Helping Babies Survive Labour is the training programme that was used to train the midwives in 
Nsambya hospital.  It was developed by Powerfree Education and Technology in Cape Town in 
collaboration with Save the Children and health professionals from Nsambya Hospital Kampala 
(Figure 3).  
Many training methods and guidelines are written in high income countries and are simply 
transferred for use in low income countries, although the healthcare workers in these countries 
may face very different challenges. Input was solicited from both the healthcare workers and 
academics in the target country in the preparation of these training materials.  
The material first provides a section of evidence-based theory that will help health workers to 
understand why monitoring of the fetal heart is important. This is followed by practical lessons on 
how to monitor fetal well-being, how to interpret observations and recordings and most 
importantly, gives guidelines on what to do when something is wr ng. The training is developed 
in such a way that it can be used along side the Helping Babies Breath training material, which 
focuses on neonatal resuscitation.  
 
Before this trial started, midwives and doctors were trained. Fifty-two people attended the 
training and 42 completed both the pre- and post-test. The average score for the pre-test was 
49.7% (median 50%). The average score for the post-test was 67.9% (median 69%). It does 
reveal the low baseline knowledge on appropriate intrapartum care and illustrates the need for 
continuous quality improvement.  
For link to the manual and its references 
http://www.healthynewbornnetwork.org/sites/default/files/resources/HBSL%20training%20bookle
t.pdf
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INTRODUCTION 
 
Approximately 44% of all child deaths under the age of 5 years occur in neonates (<28 days of 
age).[1] The third largest cause of neonatal mortality is intrapartum-related hypoxia (formerly 
called `birth asphyxia’) resulting in an estimated 660 000 neonatal deaths per year globally[1] and 
an additional 414,000 children who survive with disability.[2] There are also an estimated 1.02 
million intrapartum stillbirths almost all in low and middle income countries.[3] This burden is 
highest in areas of the world where the probability of quality of care at birth  is the lowest.[4] In 
order to reduce the incidence of intrapartum-related stillbirths and neonatal deaths, it is necessary 
to assess fetal well-being in labour with routine monitoring of the fetal heart rate (FHR), linked to 
rapid and effective  management with resuscitative measures or prompt delivery, and provision of 
neonatal resuscitation if needed.  
 
Characteristic FHR changes often precede brain injury via a process of progressive fetal hypoxic 
acidemia.[5] Intermittent auscultation as a primary screening tool to monitor fetal well-being is the 
recommended standard of care for women experiencing uncomplicated deliveries.[6-9] One 
method of intermittent auscultation uses the Pinard Fetal Stethoscope (Pinard), a trumpet shaped 
horn, to monitor the FHR and is widely adopted as the standard of care in resource-poor settings 
since it is low cost and does not require a power source or repairs. The difficulties posed in using a 
Pinard are generally not conducive to a busy labour ward. It requires additional time to precisely 
locate the fetal heart as the heart is only audible within a very narrow area of the woman's 
abdomen, it requires that the surrounding area be quiet in order to hear the fetal heart, the reading 
can be unreliable in obese women, and it requires the midwife to place her ear in close proximity 
to the woman's pubic area. In addition the midwife usually counts the FHR for short time, such as 
15 seconds, and multiplies to reach beats/minute, further decreasing accuracy and introducing 
arithmetic errors. The handheld Doppler ultrasound fetal heart rate monitor (Doppler) detects FHR 
and provides a steady state number per minute, as well as audible auscultation of the FHR. It 
requires a reliable power source and may need repairs, and is more costly than a Pinard. However, 
it permits the midwife to quickly locate the FHR, allows others including the mother to hear the 
FHR, permits the woman to remain in any comfortable position while being assessed, permits the 
midwife to both assess the FHR and communicate to the woman the status of her baby, and has 
been shown to be preferred by women over the use of the Pinard.[8,10] A rugged, wind-up, 
handheld Doppler fetal heart rate monitor (Doppler) developed by Power-free Education 
Technology (Pet.og.za) showed in initial field tests to be accurate and acceptable to both mother 
and midwives in low-resource settings.[11,12] It uses a hand crank to generate 2:30 minutes of use 
for every 30 seconds of cranking. 
 
While there have been several studies showing reduced intervention and no improved outcomes in 
the use of the intermittent (Pinard or Doppler) versus continuous cardiotocography (CTG) 
monitoring as the primary screening tool in uncomplicated deliveries,[6,13] there is little research 
on outcomes in intermittent monitoring comparing Doppler versus Pinard. A single study by 
Mohamed et al using a monitoring protocol of 10 minutes every half-hour found higher detection 
of FHR abnormalities and better perinatal outcomes in the intermittent auscultation Doppler group 
compared with the Pinard group.[14] 
 
We aimed to use a randomised trial design to compare the primary screening methods of FHR 
monitoring (Doppler as intervention versus Pinard as standard of care) on incidence of detection of 
FHR abnormalities, and on the incidence of intrapartum stillbirth and neonatal mortality in the first 
24 hours after delivery.  
Page 16 of 29
For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml
BMJ Open
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For peer review only
 5 
 
 
METHODS 
 
Study design and participants 
We undertook this randomised controlled trial at San Raphael of St. Francis Nsambya Hospital, a 
peri-urban private not-for-profit hospital in Kampala, Uganda. It is a teaching hospital that 
manages 7 500 deliveries annually. CTG and fetal blood gas sampling to support labour 
management, and epidural pain medication are not available. Oxytocin augmentation and 
Caesarean delivery rates are 40% and 20% respectively. The standard of care for intrapartum FHR 
monitoring is by intermittent auscultation using the Pinard.  
 
Women were requested to participate during an antenatal care appointment.  This consent was 
reconfirmed in labour provided that they presented in labour with a singleton pregnancy, in a 
cephalic position, at term or post-term (>37 weeks gestation). Women were excluded if they were 
already in second stage of labour upon admission or presented with a condition that, according to 
the doctor on duty, contra-indicated labouring (e.g. had a high risk pregnancy, such as 
preeclampsia or antepartum hemorrhage); if there was a diagnosis of intrauterine fetal death upon 
admission; or if the woman was admitted for an elective Caesarean delivery. Participants were 
presented with information about the study, and agreeing participants provided written consent. 
This study was approved by Sickkids Research Ethics Board, Nsambya Internal Review Board, as 
well as the Uganda National Council for Science and Technology. Registration of our protocol 
with ClinicalTrials.gov occurred before participant enrolment started, but due to an administrative 
error with our institution's Clinical Research Services Unit, the protocol was only released to the 
public after the completion of the study. Documentation from the Chair of our independent 
Research Ethics Board was provided to BMJ Open attesting to the version of the protocol 
provided to them prior to the start of enrolment. 
 
Randomisation 
Women were equally randomised to one of the two study methods using sequentially numbered, 
opaque sealed envelopes. Study participants and care providers where not blinded to the 
intervention. Data were collected from the patient's partograph and from the hospital’s routine 
neonatal mortality audit data, when applicable.  
 
Procedures 
The standard of care for intrapartum monitoring relied on partograph and FHR monitoring with 
the Pinard. Our pre-study training address deficiencies in monitoring standards (acceptable range 
for FHR, recognition of accelerations, decelerations, and change in baseline). We developed a 
training module entitled “Helping Babies Survive Labour” modeling on the “Helping Babies 
Breathe” visual materials and learning approach. The technical basis was from World Health 
Organisation (WHO) and Canadian Obstetric Society protocols.[5] All midwives and doctors 
were then given this in-service training for half a day. FHR monitoring was undertaken every 30 
minutes in first stage of labour; every 15 minutes in second stage before pushing; and every 5 
minutes in second stage when pushing and for 1 minute immediately after a contraction. The 
baseline FHR was recorded as a single number rather than a range, in the unit of beats per minute 
(bpm). The FHR rhythm (regular or irregular) and absence or presence of accelerations or 
decelerations were also documented. The maternal radial pulse was simultaneously palpated to 
differentiate it with the FHR.  
 
When FHR abnormalities are identified the standard of care would be to switch from intermittent 
auscultation to CTG. Since CTG is not available in Nsambya Hospital, any noted FHR 
Page 17 of 29
For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml
BMJ Open
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For peer review only
 6 
abnormalities were reported by the research midwife to the doctor on duty for assessment. 
Management following this assessment was either closer intermittent monitoring, or intra-uterine 
resuscitation with re-assessment of the FHR. Intra-uterine resuscitation consisted of maternal 
position change, administration of oxygen by mask to mother, initiation of intravenous infusion, 
discontinuation of oxytocin augmentation, and consider prompt delivery (assisted vaginal if 
imminent, otherwise by Caesarean). 
 
Outcomes 
The primary outcome measures of interest were detection of FHR abnormality in labour (defined 
below), intrapartum stillbirth, and neonatal deaths in the first 24 hours of life. Fetal heart rate 
abnormality is defined as tachycardia, bradycardia, or atypical variable, late or prolonged 
decelerations. Tachycardia and bradycardia are defined as baselines of >160 bpm and <110 bpm, 
respectively. Some features of atypical variable decelerations are abrupt fetal heart rate 
decelerations, lasting >2 minutes, slow return to baseline, or in the presence of tachycardia. Late 
decelerations are a repetitive, gradual decrease in the FHR and return to baseline, commencing 
after the onset of the contraction, and return to baseline after the end of the contraction. Prolonged 
decelerations are a decrease from baseline of >15 bpm lasting from 2-10 minutes. Secondary 
outcomes were Apgar score less than 7 at 5 minutes, admission to special care unit for intrapartum-
related complications (intrapartum hypoxia, neonatal encephalopathy, or meconium aspiration 
syndrome), diagnosis of neonatal encephalopathy (NE), and delivery by Caesarean.  A validated 
and simplified scoring method was used for grading mild, moderate and severe NE.[15,16] 
Indications for Caesarean delivery were failure to progress (as indicated by crossing of the action 
line on the partograph), abnormal FHR unresponsive to uterine resuscitation, and identification of 
malpresentation in labour (e.g. conversion from vertex to brow or mentum posterior). 
 
Statistical analysis 
Estimating that the use of the Doppler would reduce intrapartum stillbirth by 30% compared to the 
Pinard (based on the results of Mohamed et al 1994),[14] with 80% power to detect at least a 30% 
reduction in stillbirths with 95% confidence, we would need to enroll 840 participates in each of 
the two comparison groups. We added 20% to the sample size for each study arm to account for 
loss to follow-up and statistical adjustments and stratification, resulting in 1008 participants 
required for each comparison group. 
 
Data were double entered from the partograph and, where applicable, the hospital's routine 
neonatal mortality audit document. An interim analysis was conducted by the data safety and 
monitoring board at the mid-point of the data collection period. Descriptive statistics were used to 
describe the characteristics of the participants and their outcomes under each study arm.  
[17] 
We used population-averaged generalized Poisson regression modeling with robust variance to 
compare methods of FHR monitoring with Doppler versus Pinard on incidence rate ratio (IRR) of 
detection of FHR abnormalities, intrapartum stillbirth, and neonatal mortality (see Barros et al for 
details of this choice over logistic regression [17]). We conducted a sub-group analysis and 
qualitative reporting on the intrapartum stillbirths and pre-discharge neonatal deaths within 24 
hours and those fetuses with detected abnormal FHR. 
 
All analyses were conducted using Stata/SE (StataCorp. 2011. Stata Statistical Software: Release 
12. College Station, TX: StataCorp LP). 
 
Role of funding source 
The sponsor had no role in designing the study, analysing data, collecting data, interpreting the 
results, writing the report, or the decision to submit the paper for publication. The corresponding 
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author had complete access to all the data. 
 
RESULTS 
 
From July 2012 to December 2013, we screened 2042 women antenatally. Fifty-three women were 
ineligible (50 planned to deliver elsewhere, 3 planned Caesarean delivery); 2 women declined to 
participate; 1987 were enrolled (Figure 1). After assignment to a monitoring method, 8 of the 987 
in the Pinard arm were excluded from analysis (1 lost to follow up, 1 delivered before the 
partograph was started, 2 undiagnosed breech births, 4 undiagnosed multiple births); and 8 of the 
1000 in the Doppler arm were excluded (3 delivered before the partograph was started, 3 
undiagnosed breech births, 2 undiagnosed multiple births). The final study group was n=979 in the 
Pinard arm and n=992 in the Doppler arm. 
 
Of the 1971 women analyzed, the median maternal age was 26 years (IQR 24-30) (Table 1). There 
were a slightly higher though not statistically significant number of post-term women (≥42 weeks 
of gestational age) in the Doppler versus the Pinard arm (54/992 (5.4%) versus 41/979 (4.2%), 
p=0.193).  A similar proportion of women in the Doppler versus the Pinard arm were primiparous 
(395/992 (39.8%) versus 413/979 (42.2%)), with similar median gestational age (39 weeks, IQR 
38-40), and similar median newborn weight (3300g, IQR 3000-3500g).  
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Table 1: Demographic, clinical and perinatal characteristics 
 
  Pinard (n=979) Doppler (n=992) p-value 
Maternal age (years) Median (IQR) 26 (23-30) 27 (24-30) 0.95 
Marital status Married 816 (83.4) 818 (82.5) 0.60 
 Single 163 (16.7) 174 (17.5)  
Maternal education None 9 (0.9) 7 (0.7) 0.62 
 Primary 93 (9.5) 94 (9.5)  
 Secondary 385 (39.3) 423 (42.6)  
 Vocational 235 (24.0) 224 (22.6)  
 University 257 (26.3) 243 (24.5)  
 Missing  1 (0.1)  
Maternal occupation Housewife 357 (36.5) 377 (38.0) 0.80 
 Skilled worker 84 (8.6) 75 (7.6)  
 Self-employed 271 (27.7) 260 (26.2)  
 Professional 252 (25.7) 262 (26.4)  
 Other 15 (1.5) 18 (1.8)  
No. of ANC visits Median (IQR) 4 (3-5) 4 (3-5) 0.58 
Complication noted in 
pregnancy Yes 17 (98.3) 24 (2.4) 0.29 
 No 962 (1.7) 968 (97.6)  
Gravity 1 334 (34.1) 332 (33.5) 0.64 
 2 422 (43.1) 416 (41.9)  
 ≥3 223 (22.8) 244 (24.6)  
Parity 0 413 (42.2) 395 (39.8) 0.31 
 1 238 (24.3) 232 (23.4)  
 ≥2 328 (33.5) 365 (36.8)  
Previous perinatal death Yes 24 (2.5) 29 (2.9) 0.52 
 No 955 (97.6) 963 (97.1)  
Malarial IPTp Yes 914 (93.4) 923 (93.0) 0.78 
 No 65 (6.6) 69 (7.0)  
Syphilis Negative 830 (84.8) 869 (87.6) 0.14 
 Positive 11 (1.1) 6 (0.6)  
 Missing 138 (14.1) 117 (11.8)  
HIV Status Negative 887 (90.6) 892 (89.9) 0.55 
 Positive 46 (4.7) 57 (5.6)  
 Missing 46 (4.7) 43 (4.3)  
Gestational age at 
delivery (weeks) Median (IQR) 39 (38-40) 39 (38-40) 0.80 
Postterm gestation (≥42 
weeks) Yes 41 (4.2) 54 (5.4) 0.19 
 No 938 (95.8) 938 (94.6)  
Newborn weight (g) Median (IQR) 3300 (3000-3500) 3300 (3000-3500) 0.70 
Data are n (%) or median (IQR); IPTp - Intermittent preventative treatment in pregnancy; HIV - Human 
immunodeficiency virus 
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There were no differences between the study arms in Apgar score <7 at 5 minutes (23 (2.3%) in 
the Doppler versus 17(1.7%)  the Painard, p=0.40) or admission to neonatal intensive care unit for 
any reason (48(4.8%) in the Doppler versus 36(3.7%) the Pinard, p=0.20). Similar proportions of 
women in the Doppler versus Pinard arm had Caesarean deliveries (175/992 (17.6%) versus 
166/979 (17.0%), p=0.695).  
 
There were a significantly higher number of FHR abnormalities detected in the Doppler versus 
Pinard arm (75/992 (7.6%) versus 46/979 (4.7%), p=0.008, IRR=1.61, 95%CI 1.13-2.30) (Table 
2). There were a higher though not statistically significant number of intrapartum stillbirths in the 
Doppler versus Pinard arm (4/988 (0.4%) versus 1/977 (0.1%), p=0.184, IRR=3.94, 95%CI 0.44-
35.24), and higher number of neonatal deaths prior to discharge (7/985 (0.7%) versus 5//973 
(0.5%), p=0.579, IRR=1.38, 95%CI 0.44-4.34).  
 
There were 121 cases of abnormal FHR detected in labour (Figure 2). Of the 17 deaths in total 
(intrapartum stillbirths and neonatal deaths prior to discharge), 5 were associated with the detection 
of abnormal FHR in labour. In a subgroup analysis of those cases where abnormal FHR was 
detected, there were a higher though not statistically significant proportion of deaths in the Doppler 
versus Pinard arm (4/71 (5.3%) vs 1/45 (2.2%), IRR=2.45 95%CI 0.28-21.47). The remaining 12 
deaths who had a normal FHR reported; 3 had missing cause of death, and 1 had a congenital 
anomaly, and cause of death for the remaining 8 was intrauterine hypoxia, respiratory distress, or 
neonatal encephalopathy, suggesting that an abnormal FHR was a missed diagnosis in labour for 
these 8 deaths.  
 
Table 23: Primary outcomes by treatment group 
    
Pinard 
(n=979) 
Doppler 
(n=992) p value  IRR
*
 (95% CI) p value 
Abnormality 
detected Yes 46 (4.7) 75 (7.6) 0.008 1.61 (1.13 to 2.30) 0.009 
 No 933 (95.3) 917 (92.4)    
Intrapartum 
stillbirth Yes 1 (0.1) 4 (0.4) 0.184 3.94
**
 (0.44 to 35.24) 0.219 
 No 977 (99.9) 988 (99.6)    
 Missing 1 0    
        
Neonatal death 
prior to discharge Yes 5 (0.5) 7 (0.7) 0.579 1.38
**
 (0.44 to 4.34) 0.552 
 No 973 (99.5) 985 (99.3)    
 Missing 1     
IRR - incidence rate ratio; 
*
not adjusted, significant baseline characteristics (p value <0.2) were tested and 
did not influence measure of effect in the model 
**
excludes missing from analysis 
 
DISCUSSION 
 
Detection of abnormal FHR in labour is essential for identifying the fetus in need of responsive 
management such as prompt delivery. We report that intermittent auscultation with a Doppler 
identifies 60% more in need of prompt delivery (IRR=1.61); however, we did not find that this 
identification resulted in a significant decrease in mortality, although one would expect that higher 
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detection should lead to prompt delivery and improved outcomes.  
 
We propose a number of explanations for this lack of detected impact. We considered that there 
may have been a learning curve for staff using the Doppler as a new technology; however, we 
found no difference in outcomes over time or between groups (data not shown). Secondly, it is 
possible that use of technology such as the Doppler lead to false reassurance that FHR was being 
closely monitored, delayed involvement of senior staff and subsequent delivery, or there may 
simply have been delay between recognition and action that, by chance, had more deleterious 
effects in the intervention group. Thirdly this study sample size and power was based on the 
Mohamed 1994 study, aiming to detect a 30% reduction in intrapartum stillbirth in the Doppler 
compared to the Pinard group and this may be optimistic, necessitating a larger sample size to 
demonstrate any improved outcomes given the improved detection rates in the Doppler group.  
 
Some study limitations include that we were unable to perform secondary screening of suspected 
fetal hypoxia through the use of cardiotography; nor confirm for the presence of fetal hypoxia 
acidemia via fetal blood scalp sampling, and cord blood gases; therefore we were unable to assess 
if the identification (or lack of identification) of abnormal FHR was correlated with the presence of 
fetal hypoxia acidemia. In addition, we were unable to exclude some cases where the underlying 
cause of death was other than f tal hypoxia (e.g. congenital anomalies, early onset sepsis) due to 
diagnostic limitations in differentially diagnosing these cases. Finally, the screening process was 
all linked to the partograph which has well recognized limitations.[18]  
 
In conclusion, routine monitoring with a handheld Doppler increases the proportion of fetuses 
identified in need of prompt delivery via the identification of FHR abnormalities in labour; 
The care providers and the women expressed preferences for the Doppler, however, we did not 
find evidence that this lead to a decrease in the incidence of intrapartum stillbirth or neonatal death. 
While assessing user satisfaction was not the objective of this study, the care providers and the 
women expressed preference for the Doppler, and given that the Doppler performed no worse than 
the Pinard in detecting abnormal FHR or in newborn survival, this should be an area of further 
research. Finally, tThis study demonstrates the need for a further larger study with linkage to rapid 
response for abnormal FHR, including caesarean section to ensure that increased detection using 
the Doppler leads to decreased death and disability.  
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CONSORT 2010 checklist of information to include when reporting a randomised trial* 
 
Section/Topic 
Item 
No Checklist item 
Reported 
on page No 
Title and abstract 
 1a Identification as a randomised trial in the title 1 
1b Structured summary of trial design, methods, results, and conclusions (for specific guidance see CONSORT for abstracts) 2 
Introduction 
Background and 
objectives 
2a Scientific background and explanation of rationale 4 
2b Specific objectives or hypotheses 4 
Methods 
Trial design 3a Description of trial design (such as parallel, factorial) including allocation ratio 5 
3b Important changes to methods after trial commencement (such as eligibility criteria), with reasons not applicable 
Participants 4a Eligibility criteria for participants 5 
4b Settings and locations where the data were collected 5 
Interventions 5 The interventions for each group with sufficient details to allow replication, including how and when they were 
actually administered 
5 
Outcomes 6a Completely defined pre-specified primary and secondary outcome measures, including how and when they 
were assessed 
6 
6b Any changes to trial outcomes after the trial commenced, with reasons not applicable 
Sample size 7a How sample size was determined 6 
7b When applicable, explanation of any interim analyses and stopping guidelines 6 
Randomisation:    
 Sequence 
generation 
8a Method used to generate the random allocation sequence not reported 
8b Type of randomisation; details of any restriction (such as blocking and block size) 5 
 Allocation 
concealment 
mechanism 
9 Mechanism used to implement the random allocation sequence (such as sequentially numbered containers), 
describing any steps taken to conceal the sequence until interventions were assigned 
5 
 Implementation 10 Who generated the random allocation sequence, who enrolled participants, and who assigned participants to 
interventions 
5 
Blinding 11a If done, who was blinded after assignment to interventions (for example, participants, care providers, those 5 
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assessing outcomes) and how 
11b If relevant, description of the similarity of interventions 5 
Statistical methods 12a Statistical methods used to compare groups for primary and secondary outcomes 6 
12b Methods for additional analyses, such as subgroup analyses and adjusted analyses 6 
Results 
Participant flow (a 
diagram is strongly 
recommended) 
13a For each group, the numbers of participants who were randomly assigned, received intended treatment, and 
were analysed for the primary outcome 
Figure 1, 6-7 
13b For each group, losses and exclusions after randomisation, together with reasons Figure 1, 6-7 
Recruitment 14a Dates defining the periods of recruitment and follow-up 6 
14b Why the trial ended or was stopped 6 
Baseline data 15 A table showing baseline demographic and clinical characteristics for each group 8 
Numbers analysed 16 For each group, number of participants (denominator) included in each analysis and whether the analysis was 
by original assigned groups 
8 
Outcomes and 
estimation 
17a For each primary and secondary outcome, results for each group, and the estimated effect size and its 
precision (such as 95% confidence interval) 
10 
17b For binary outcomes, presentation of both absolute and relative effect sizes is recommended 10 
Ancillary analyses 18 Results of any other analyses performed, including subgroup analyses and adjusted analyses, distinguishing 
pre-specified from exploratory 
9 
Harms 19 All important harms or unintended effects in each group (for specific guidance see CONSORT for harms) Table 2, 9 
Discussion 
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, multiplicity of analyses 10 
Generalisability 21 Generalisability (external validity, applicability) of the trial findings 10 
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and considering other relevant evidence 10 
Other information  
Registration 23 Registration number and name of trial registry 2 
Protocol 24 Where the full trial protocol can be accessed, if available 2 
Funding 25 Sources of funding and other support (such as supply of drugs), role of funders 2 
 
*We strongly recommend reading this statement in conjunction with the CONSORT 2010 Explanation and Elaboration for important clarifications on all the items. If relevant, we also 
recommend reading CONSORT extensions for cluster randomised trials, non-inferiority and equivalence trials, non-pharmacological treatments, herbal interventions, and pragmatic trials. 
Additional extensions are forthcoming: for those and for up to date references relevant to this checklist, see www.consort-statement.org. 
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